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End! stage! kidney! disease! (ESKD)! affects! over! 53,00! people.! ! The! progression! of!
chronic! kidney! disease! (CKD)! to! ESKD! is! characterised! by! cytokine! stimulation,!
leading!to!the!activation!of!myofibroblasts,!resulting!in!fibrosis.!!Kirsten!rat!sarcoma!
(KNRas)!has!a!key!role!in!the!proliferation!of!renal!fibroblasts! in#vitro!and!has!been!
highlighted! as! a! possible! target! for! fibrosis.! ! Previous! research! in! our! laboratory!
showed!that!inhibiting!KNRas!in!the!UUO!model!inhibited!renal!fibrosis.!!
 
The! aim! of! this! thesis! was! to! investigate! the! outcome! of! inhibiting! KNRas! using!






associated! with:! 37%N50%! reduction! in! total! collagen! and! protection! of! renal!
function! (BUN)! in! the! 12!week! CFAN!model.! #TGFβ1! treated! cells! showed! an! upN
regulation! in!KNRas,! Jag!1!and!Collagen!1a!mRNA.! !Treatment!with!KNRas!ASO!was!
associated!with!a!3.5!fold!reduction!in!Jag!1!and!a!55%!reduction!in!collagen!1a.!!Jag!
1! has! been! linked! to! the! progression! of! renal! fibrosis! via! biNdirectional! signalling!
with!Notch!1.!!
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“Antisense! Oligonucleotides! Targeting! Kirsten! Ras! Reduce! Interstitial! Fibrosis! and!











“Silencing! KNRas! reduces! Renal! fibrosis! in! UUO! model! but! does! not! affect! the!




“Mutations! in! TJP2! cause! progressive! cholestatic! liver! disease.”! Sambrotta! M,!
Strautnieks! S,! Papouli! E,! Rushton! P,! Clark! BE,! Parry! DA,! Logan! CV,!Newbury! LJ,!
Kamath! BM,! Ling! S,! Grammatikopoulos! T,!Wagner! BE,!Magee! JC,! Sokol! RJ,!MieliN
Vergani! G;! University! of! Washington! Center! for! Mendelian! Genomics,! Smith! JD,!









































































































































































































































































AA! ! ! Aristolochic!acid!
ACE! ! ! Angiotensin!converting!enzyme!
ACEi!! ! ! Angiotensin!converting!enzyme!inhibitor!
ACTH! ! ! Adrenocorticotrophic!hormone!
AKI! ! ! Acute!kidney!injury!
αNSMA!! ! Alpha!smooth!muscle!actin!
AT1R! ! ! Angiotensin!II!type!1!receptor!
AT2R! ! ! Angiotensin!II!type2!receptor!
Ang!II!! ! ! Angiotensin!II!
ARB!! ! ! Angiotensin!receptor!blocker!
ASO!! ! ! Antisense!Oligonucleotides!
BP! ! ! Blood!pressure!
BSA! ! ! Bovine!serum!albumin!!
BUN! ! ! Blood!Urea!Nitrogen!
BrdU!! ! ! Bromodeoxyuridine!
cDNA! ! ! Complementary!DNA!
CFAN! ! ! Chronic!Folic!Acid!Nephropathy!
CTGF!or!CCN2! ! Connective!Tissue!growth!factor! !
CKD!! ! ! Chronic!kidney!disease!




DN! ! ! Diabetic!Nephropathy!!
DNTP! ! ! Deoxyribonucleotide!triphosphate!
ECM!! ! ! ExtraNcellular!matrix!
EDTA!! ! ! Ethylenediaminetetraacetic!acid!
eGFR!! ! ! Estimated!glomerular!filtration!rate!
EndNMT! ! Endothelium!Meschymal!Transition!
EMT! ! ! Epithelial!Meschymal!Transition!
ERK! ! ! Extracellular!signalNregulated!kinases!
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ESKD!! ! ! EndNstage!kidney!disease!
ETN1! ! ! EndothelinN1!
ETOH!! ! ! Ethanol!
FCS!! ! ! Fetal!calf!serum!
FGF!! ! ! fibroblast!growth!factor!
FTIs! ! ! Farnesyltransferase!inhibitors!
FTS! ! ! Farnesylthiosalicylic!acid!
FSGS!! ! ! Focal!segmental!glomerulosclerosis!
GAPDH!! ! Glyceraldehyde!3Nphosphate!dehydrogenase!
GBM! ! ! Glomerular!basement!membrane!
GDP! ! ! Guanosine!diphosphate!
GGTIs! ! ! Geranylgeranyltransferase!I!inhibitor!
GH!! ! ! Growth!hormone!
GHRF!! ! ! Growth!hormone!releasing!factor!
GRB2! ! ! Growth!factor!receptorNbound!protein!2!
GPCR! ! ! GNprotein!coupled!receptor!
GTP! ! ! GuanosineN5’!triphosphate!
HCL! ! ! Hydrogen!Chloride!
H&E! ! ! Hematoxylin!and!eosin!stain!
HKC! ! ! Human!Kidney!Cells!
HRP! ! ! Hydrogen!Peroxide!
HNRas! ! ! Harvey!Rat!Sarcoma!
HIER!! ! ! HeatNinduced!epitope!retrieval!
IHC! ! ! Immunohistochemistry!
IGF!! ! ! InsulinNlike!growth!factor!!
IgG!! ! ! Immunoglobulin!G!
IMS! ! ! Industrial!methylated!spirit!
ITS! ! ! Insulin!transferrin!selenium!
IV! ! ! Intravenous!!
KNRas!or!KiNRas! Kirsten!Rat!Sacroma!protein!and!mRNA!




MEK! ! ! MitogenNactivated!protein!kinase!kinase!
MGN! ! ! Membranous!glomerulonephritis!
MT! ! ! Masson’s!Trichrome!
MPGN! ! ! Membranoproliferative!glomerulonephritis!
MPTECs! ! Mouse!Proximal!Tubule!Epithelial!Cells!
MMPs! ! ! Matrix!Metalloproteinase!Enzymes!
MSP! ! ! Methylation!Specific!PCR!
mRNA!!! ! Messenger!ribonucleic!acid!
NNRas!! ! ! Neuronal!Rat!Sacroma!
PBS!! ! ! Phosphate!buffered!saline!
PTECs! ! ! Proximal!Tubular!Cells!
PBST! ! ! Phosphate!buffered!Saline!with!0.1%!tween!
PCR! ! ! Polymerase!Chain!Reaction!
PDGF!! ! ! Platelet!derived!growth!factor!
PKC! ! ! Protein!kinase!C!
PI3K! ! ! PhosphatidylinositolN3Nkinase!
PMT! ! ! PicroNmallory!Trichrome!
PSR! ! ! PicroNSirius!Red!
RAAS! ! ! ReninNangiotensinNaldosterone!system!
RAS! ! ! Rat!Sarcoma!
Ras!Gaps! ! Ras!GTPases!activating!Proteins!
Ras!GEFs! ! Ras!Guanine!nucleotide!exchange!factor!
RBD! ! ! Ras!binding!domain!
RFP!! ! ! Red!fluorescent!protein!!
RNA!! ! ! Ribonucleic!acid!
RRT!! ! ! renal!replacement!therapy!
RNT! ! ! Reverse!Transcription!
RT! ! ! Room!temperature!
RTK! ! ! Receptor!Tyrosine!Kinases!
RTNPCR!! ! reverse!transcriptaseNpolymerase!
SC!! ! ! Subcutaneous!!
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SDS! ! ! Sodium!dodecyl!sulfate!
siRNA!! ! ! Small!interfering!ribonucleic!acid!
Sos! ! ! Son!of!Sevenless!
TAE!buffer!! ! TrisNacetateNEDTA!buffer!
TBM! ! ! Tubular!basement!membrane!
TBS!! ! ! Tris!Buffered!Saline!
TBST! ! ! Tris!Buffered!Saline!with!0.1%!Tween!
TGN2! ! ! Transglutaminase!2!
TGFβ!! ! ! transforming!growth!factor!beta!
TIMPs! ! ! Tissue!inhibitors!of!Matrix!metalloproteinases!
UUO! ! ! Unilateral!ureteral!Obstruction!!






also!highly!prevalent!with!53,207!people! requiring! renal! replacement! therapies! in!
the!UK!in!2011;!a!rate!of!842!per!million!population!(pmp)!and!a!3%!increase!on!the!
2009! figures! (Registry!2012).! !ESKD! is! the!end!result!of! slowly!progressive!chronic!
kidney!disease! (CKD),!which! in!developed!countries,! is!most! commonly! caused!by!
hypertension! and! diabetes,!with! other! causes! including! glomerulonephritis,! other!
















































left! column! with! Stage! 1! being! a! patient! with! a! healthy! eGFR! =! estimated!
glomerular! filtration! rate,! but! has! shown! other! signs! of! reduced! kidney! function,!





Many!patients! suffering! from!CKD!have!high!blood!pressure! (hypertension).! ! This!
can!either!be!a!cause!or!consequence!of!CKD.!!In!some!patients!it!develops!early!but!
in! others! it! is! a! marker! of! worsening! renal! function.! ! In! either! scenario! it! is!
associated!with! increasing! rate! of! decline! of! renal! function! and! increased! risk! of!
cardiovascular! disease.! In! a! large! population! analysis,! hypertension! was! a! strong!
independent! risk! factor! for!ESKD! (Tozawa,! Iseki!et!al.!2003).!Good!blood!pressure!
control! is! therefore! vital! to! protect! kidney! function! and! patients! are! often!
prescribed! antiNhypertensives,! most! commonly! ACE! inhibitors! (ACEi),! angiotensin!





Unfortunately,! even! with! good! blood! pressure! control,! many! patients! with! CKD!
continue! to!progress! to!ESKD.!These!patients! require! renal! replacement! therapies!
such!as!haemodialysis,!or!peritoneal!dialysis.!!!These!therapies!do!not!cure!CKD!but!







Fibrosis! is! a! hallmark! of!many! chronic! diseases! and! occurs! across!multiple! organ!
systems!in!the!body.!!Once!tissues!have!been!injured!or!challenged,!a!repair!process!
is! triggered,!usually! resulting! in! the!expression!of! cytokines! such!as!TGFβ1.!These!
are! released! as! the! body! attempts! to! heal! the! wound/damaged! area.! ! Wound!
healing! is! defined! as! a! limited,! controlled! and! temporary! response! that! results! in!
organ!function!being!restored!(Leask!and!Abraham!2004).!!Fibrosis!is!believed!to!be!
an! evolutionary! extension! of! wound! healing,! when! the! tissue! can! no! longer!
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terminate!the!process.!Fibrosis!is!defined!as! ‘the!formation!of!scarring!or!excess!of!
fibrous! connective! tissue! in! an! organ,! resulting! in! the! organ’s! malfunction! and!
death’.! ! It! is! an! uncontrolled! response! to! severe! or! repetitive! injury! and! is! a!





occurs! after! tubular! damage! is! termed! tubulointerstitial! fibrosis,! in! which! the!
degree!of!scarring!correlates!with!kidney!function!(Cohen!1995).!!Tubulointerstitial!
fibrosis! is! defined! by! its! histopathology:! deposition! of! extracellular! matrix! and!
tubular!cell!loss,!resulting!from!myofibroblast!accumulation!in!the!kidney!(Zeisberg!
and! Neilson! 2010).! ! The! other! form! of! fibrosis! is! seen! in! the! glomerulus! of! the!
kidney!and!is!referred!to!as!glomerulosclerosis.!!This!is!associated!with!depletion!of!
visceral! epithelial! cells! known! as! podocytes,! an! increase! in! mesangial! cell!
proliferation!and!laying!down!of!extracellular!mesangial!matrix.!!In!the!early!stages!
this! is! often! focal! and! segmental! in! nature! but! can! progress! to! global!
glomeruosclerosis! as! the! disease! advances.! During! the! disease! progression!
detachment!of!podocytes!from!the!glomerular!basement!membrane!(GBM)!results!
in! damage! to! the!GBM! and! the! development! of! proteinuria.! The! leaked! proteins!











One!of! the!most! controversial!debates! in! fibrosis! research!over! the!past!10!years!
has! been! around! the! origin! of! the! myofibroblast.! ! Many! people! believe! that!
understanding!the!origin!of!this!cell!will!help!us!to!accelerate!the!finding!of!an!antiN
fibrotic!therapy.!!The!five!main!theories!of!the!cellular!precursors!for!myofibroblasts!






of! epithelial! to! mesenchymal! transition! (EMT),! whereby! tubuloepithelial! cells!
undergo! phenotypic! change! to! become! mesenchymal! in! nature,! was! the!
predominant!source!of!the!myofibroblasts! in!the!fibrosing!kidney!(Iwano,!Plieth!et!
al.! 2002,! Rastaldi,! Ferrario! et! al.! 2002,! Higgins,! Kimura! et! al.! 2007,! Zeisberg! and!
Duffield!2010).!!EMT!is!a!process!that!is!widely!recognised!in!ontogeny.!!Type!1!EMT!
occurs!during!the!early!stages!of!embryogenesis,!allowing!primitive!epithelial!cells!




forward! the! hypothesis! that! EMT! occurs! in! renal! fibrosis! in! 1995! suggesting! that!
tubuloepithelial! cells! in! the! kidney! (parenchymal! cells)! have! the! ability! to! move!
through!the!tubulobasement!membrane!(TBM)!and!fill! the! interstitial!space!whilst!
transitioning! into!a!myofibroblast.! !Tubuloepithelial!cells!are!a!single! layer!of!cells!
that!are!connected!together!through!junctions!located!on!their!basolateral!surfaces.!!
The! apical! and! basolateral! surfaces! of! the! cell! differ! from! each! other,! containing!
specific! transporters! and! membrane! proteins,! giving! the! cell! polarity.! ! This!
characteristic! is!not! seen! in!other! cell! types! such!as! fibroblasts!or!myofibroblasts.!
The!hypothesis!is!that!in!disease!conditions,!the!tubuloepithelial!cells!are!subjected!
to! an! insult,! causing! surrounding! cells! to! produce! proteases.! ! These! proteases!
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dissolve!the!TBM,!allowing!cells!to!pass!through!and!fill!the!interstitial!space!and!to!




occurs! in! an! in# vivo! setting.! The! strongest! evidence! to! validate! this! hypothesis! is!
from!in#vitro!work,!where!the!data!clearly!shows!that!proximal!tubular!cells!(PTECs)!
do! undergo! EMT! when! stimulated! with! TGFβ.! This! cytokine! causes! a! loss! in!
epithelial! markers! such! as! ENcadherin! and! an! increase! in! expression! of! markers!
associated!with!myofibroblast!such!as!alphaNsmooth!muscle!actin!(αNSMA).! !These!
cells! are! capable! of! laying! down! ECM! components! such! as! fibronectin,! collagen! I!
and! collagen! III.! ! However,! in! the! in# vitro! setting! there! is! no! tubular! basement!




In! recent!years! researchers!have! tried! to!elucidate! the!origin!of!myofibroblasts! in#
vivo! using! fate! mapping! and! lineage! models.! Jeremy! Duffield’s! group! has! used!
numerous! transgenic! mouse! models! to! examine! the! fate! of! three! different! cell!
populations:! mesonephric! duct! (collecting! ducts! and! ureteral! epithelium),! nonN
ureteric! budNderived! (proximal! tubules,! podocytes! and! loop! of! henle)! and! renal!
stroma!cells,!as!they!transition!through!the!fibrotic!response.!Following!10!and!14!
days! of! unilateral! ureteric! obstruction,! cells! of! epithelial! origin! were! seen! in! the!




proportion! of! myofibroblasts! within! the! kidney! are! derived! from! epithelial! cells!
(Humphreys,!Lin!et#al.!2010).!!However!utilizing!similar!techniques,!Lebleu!et#al!have!






























































































Pericytes! are! perivascular! fibroblasts! and! have! been! the! focus! of!work! in! Jeremy!
Duffield’s! lab! for!a!number!of!years.! !This!group!performed! lineage!analysis!using!
the!Foxd1!promoter!mice!crossed!with!a! lacZ!reporter!mouse.! ! !Foxd1!is!a!marker!
for! all! cells! fated! to! become! stromal! cells,! including! mesangial! cells,! vascular!
smooth! muscle! cells! and! pericytes,! but! not! endothelial! cells.! ! By! coNstaining! for!
PDGFRNβ! they!concluded! that!all!pericytes!originated! from!Foxd1!progenitor!cells.!
On!analysis!of! the!Foxd1/lacZ! reporter! in!healthy!mice!no!αNSMANexpressing! cells!
were!present!in!the!interstitium!of!the!kidney.!!However,!after!14!days!of!unilateral!
ureteral! obstruction! (UUO),! not! only! was! there! a! marked! expansion! in! lacZN





to! become! stroma! cells.! ! In! Foxd1NGC;! R26R! adult! reporter! mice,! lacZ! showed!
expression!of!Foxd1! in!messagnial!cells,!kidney!vascular!smooth!muscle!and!many!
interstitial! cells.! ! The! interstitial! cells! also! expressed! the! PDGFRNβ! marker! for!
pericytes.! !From!this! they!concluded!that!Foxd1!was!a!marker! for!progenitor!cells!
for!the!pericyte! in!this!mouse!too.! !Following!14!days!of!UUO!injury!there!was!an!
expansion!in!lacZ/Foxd1!expressing!cells!in!the!interstitium!that!all!coNlocalised!with!





process,!but! some!questions! remain!unanswered.!Are!pericytes! the!only! cell! type!
that! contribute! to! the!myofibroblast! pool! in! renal! fibrosis?! Can! other! cells! types,!





answer! these! questions.! ! They! took! a! different! approach! to! Duffield’s! group! and!




in! the! interstitium! (LeBleu,!Taduri!et!al.!2013).! !They!used! two!different!but!wellN
accepted!markers!of!pericytes,!NG2!and!PDGFRNβ!as!opposed!to!the!Foxd1!marker!
used! in! the! work! of! Duffield! et# al.! ! NG2! is! a! cellNsurface! chondroitin! sulfate!
proteoglycan! and! NG2! labeling! was! increased! in! the! interstitium! of! obstructed!
kidneys! compared! with! healthy! kidneys.! Similarly,! PDGFRNβ expression! was!
upregulated! in! the! obstructed! kidneys! of! PDGFRNβNYFP! mice.! ! However! these!
markers! did! not! coNlocalise! with! αNSMA,! suggesting! that! the! pericytes! did! not!
differentiate!into!myofibroblasts,!despite!increasing!in!number.!!By!using!a!genetic!
model!to!ablate!these!cells!the!group!looked!to!see!if!they!play!a!functional!role!in!












compared!with! immuneNstaining,! suggesting! that! the!bone!marrow!contributes! to!
35%!of!myofibroblasts!in!disease!(LeBleu,!Taduri!et!al.!2013).!!In!addition,!in!αNSMAN
RFP! mice! post! injury,! 50%! of! the! αNSMA! producing! cells! coNstained! for! the!
proliferation!marker!Ki67,!suggesting!that!the!other!50%!of!myofibroblasts!were!not!
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proliferating!and!were! recruited! from! the! circulation!with!no!need! for!expansion.!!
By!looking!at!the!coNstaining!of!Ki67!and!αNSMA!in!their!bone!marrow!studies!they!





to!the!myofibroblast!population.! !They!are!described!as!a!thin,! flattened!cell,! that!
lines!the!inside!surfaces!of!body,!blood!vessels,!and!lymph!vessels,!thus!making!up!
the! endothelium.! ! In! 2008! Zeisberg! et! al! used! three! models! of! renal! fibrosis! to!
determine!if!endothelial!cells!also!contributed!to!renal!fibrosis!as!they!had!shown!to!
be! the! case! in! cardiac! fibrosis.! ! Using! the! maker! C31,! endothelial! cells! were!
monitored!in!three!models!of!Renal!fibrosis:!UUO,!streptozotocinNinduced!diabetic!
nephropathy! and! Alport disease,! Zeisberg! et! al! reported! that! in! all! three!mouse!
models,! a! considerable!portion!of! activated! fibroblasts! coNexpress! the!endothelial!
marker! CD31,! indicating! that! these! fibroblasts! likely! carry! an! endothelial! imprint.!!
Further!fate!mapping!experiments!were!undertaken!in!the!UUO!model!using!Tie2N
Cre;! R26RNstopNEYFP! transgenic! mice.! ! Analysis! of! these! mice! revealed! yellow!
fluorescence! protein! (YFP)! expression! in! a! substantial! portion! of! the! activated!
fibroblasts! (30N50%),! thus! causing! Zeisberg! et! al! to! infer! that! endothelial! cells! do!
contribute!to!the!myofibroblast!population.!!However!the!Kalluri!laboratory!in!2013!
debated! the! percentage! of! contribution! that! endothelial! cells! really! had! to! the!










Extracellular! matrix! (ECM)! is! a! very! dynamic! highly! charged! structure.! Under!!
normal!conditions! the!ECM!acts!as!a!structural! support! for! the!cell!but!also!as!an!
active!cellNsignalling!component.!!The!ECM!is!composed!of!collagens,!glycoproteins!
and!elastin!molecules,!which! form!a!complex!network! interacting!with!each!other!
and! surrounding! cells.! !Matrix!deposition!and!degradation! is! a! carefully! regulated!
process!and! is! controlled!by! two!major!groups!of!proteolytic!enzymes:! the!matrix!
metalloproteinase!enzyme!family!(MMPs)!and!the!plasminogen/plasmins!and!their!
inhibitors:! tissue! inhibitors! of! matrix! metalloproteinases! (TIMPs)! or! plasminogen!
activator!inhibitors!(PAI)!respectively!(Genovese,!Manresa!et!al.!2014).!
!
The! ECM!differs! between! the! glomeruli! and! interstitium! allowing! for! its! different!
functions.!!In!the!glomeruli!ECM!is!present!in!the!glomerular!basement!membrane,!
Bowman’s!capsule!and!between!mesangial!cells,!whereas!in!the!tubulointerstitium!
it! is! present! in! the! basement! membrane,! capillary! basement! membrane! and!
interstitial!space.!!The!interstitial!ECM!is!normally!composed!of!collagen!types!I,!III,!
V,! VI,! VII! and! XV,! both! sulphated! and! nonNsulphated! glycosaminoglycans,!
glycoproteins!and!polysaccharides!(Genovese,!Manresa!et!al.!2014).!
!
During! fibrosis! the! formation! of! scar! tissue! is! the! result! of! the! excessive!
accumulation!of!ECM!components.! !Collagen!is!the!main!structural!element!of!the!
interstitial!ECM!with!Collagen!I!accumulation!being!seen! in!renal! fibrosis.!Similarly!
Collagen! III! is!expressed!at! low! levels! in! the!healthy!kidney!but!expressed!at!high!
levels!in!the!disease!kidney!as!demonstrated!by!Soylemezoglu!et#al!in!human!renal!





have! key! roles! in! the! kidney.! ! MMPs! 1,! 8! and! 14! are! interstitial! collagenases,!
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degrading!collagen!I!and!III!and!MMP2!and!N9!are!gelatinases!effecting!collagen!IV,!
fibronectin!and! laminin! (Lenz,!Elliot!et!al.!2000).! ! The!kidney!also!expresses! three!
TIMPs:!TIMP1,!TIMP2!and!TIMP3!that!have!been!shown!to!inhibit!different!MMPs.!
The!roles!of!MMPs!and!TIMPs!in!fibrosis!have!been!explored!using!the!UUO!model.!!
In! this!model! there! is!an!early! increase! in!MMP2! (type! IV!collagenase)!expression!
and! activity.! ! Along! side! this! there! is! a! reduction! in! MMP1! and! 9! activity! (Du,!
Shimizu!et!al.!2012).! !Johnson!et#al!showed!a!reduction!in!most!MMPs!in!the!5/6N
nephrectomy!model!of!renal!fibrosis!looking!at!both!an!RNA!and!protein!activation!
level.! ! However,! RNA! and! protein! activation! was! increased! for! both! MMP1! and!











family.! It! irreversibly! crosslinks! ECM!proteins!with! the! formation! of! lysine! bonds,!
which! has! been! demonstrated! in! both! experimental! and! human! CKD! (Johnson,!
Griffin!et!al.!1997,!Johnson,!ElNKoraie!et!al.!2003).!!The!increased!expression!of!TG2!






covalent! alpha/beta!heterodimers! and!many!members!of! the! family!have!distinct!













The!principle! laminin!Receptors! include!α3β1,!α6β1!and!α6β4.! !α3β1! is! the!most!
highly! expressed! laminin! receptor! in! the! kidney,! is! found! in! both! glomeruli! and!
tubules!and!has!key!roles!in!kidney!organogenesis!(Kreidberg,!Donovan!et!al.!1996).!!
α3! knockout! mice! have! abnormalities! in! both! the! collecting! system! and! the!
glomeruli.! Mice! with! a! specific! α3! deletion! in! podocytes! show! a! severe!
developmental! phenotype! characterised! by! foot! process! effacement! and! heavy!
proteinuria!(Sachs,!Kreft!et!al.!2006).!!Selective!knockouts!for!β1!show!a!very!similar!
but! less! severe! phenotype! (Kanasaki,! Kanda! et! al.! 2008,! Pozzi,! Jarad! et! al.! 2008).!!
These! findings! suggest! that!α3β1! is! involved! in!podocyte! stability! and! glomerular!
development! (Liu,! Chattopadhyay! et! al.! 2009).! ! Conversely,! an! α3! deletion!
specifically! in! the! collecting! duct! leads! only! to! a! mild! renal! developmental!
phenotype.! In! humans! α3β1! mutations! lead! to! severe! renal! abnormalities! and!
premature! death.! ! Children! with! homozygote! deletions! or! missense! mutations!
develop!atrophic!glomeruli,! focal!and!segmental!glomerulosclerosis! (FSGS),!diffuse!
interstitial! fibrosis! and! tubular! atrophy! (Has,! Sparta! et! al.! 2012,! Nicolaou,!
Margadant! et! al.! 2012).! ! α3β1! binds! to! CD151! to! regulate! its! function! and!










The! two!major! collagen! receptors! are! the! integrins!α1β1! and!α2β1! and! they! are!
widely! expressed! in! the! kidney! and! in! leukocytes.! Integrin! α1β1! primarily! binds!
collagen!type!IV,!a!major!constituent!of!basement!membranes,!whereas!α2β1!binds!
collagen! type! I,! the! expression! of! which! is! upregulated! in! renal! disease.!!
Interestingly,!α2!null!mice!exhibit!normal!renal!development!(Girgert,!Martin!et!al.!
2010).!!In!the!rat!model!of!nephrotoxic!nephritis,!Cook!et#al#showed!that!treatment!






integrins! (α5b1,! α8b1)! and! five! αV! integrins! (αvβ1,! αvβ3,! αvβ5,! αvβ6,! and!
αvβ8)(Pozzi! and! Zent! 2013).! ! It! has! been! shown! that!α5β1! has! no!major! role! in!
kidney! disease,! whereas! constitutive! deletion! of! the! integrin! α8! leads! to! renal!
agenesis,! due! to! loss!of!binding! to!nephronectin.! ! ! There! is! strong!evidence! for! a!
role! of! the! αV! family! of! integrins! in! the! pathogenesis! of! liver,! lung! and! kidney!
fibrosis.! ! αVβ6! targeting! appears! to! be! an! effective! way! of! dampening! TGFβ!
signalling! and! in!PDGFRβ<CreNknockout!mice! for! the!αV! subunit,! Henderson! et# al#












growth,! apoptosis! and! differentiation.! TGFβ! is! the! founding!member! of! the! TGFβ!
superfamily,! which! includes! activins,! inhibins,! growth! differentiation! factors! and!
bone!morphogenetic! proteins.! ! All! cell! types! inside! the! kidney! secrete! the! three!
mammalian!TGFβ! isoforms!1,!2!and!3,!as!do!the! infiltrating! inflammatory!cells.!All!
three!TGFβ!isoforms!share!a!highly!similar!structure;!all!have!the!NNterminal!section!
for!excretion!from!the!cell!while!the!C!terminal!encodes!the!active!portion.!!TGFβ1!
is! the! isoform!that!plays!the!major!role! in!CKD.! ! It! is!secreted! in! its! inactive! form,!
which!is!referred!to!as!latent!TGFβ1.!!Latent!TGFβ1!is!bound!to!latent!–TGFβ!binding!
proteins!(LTBP).!!Latent!TGFβ1!becomes!active!when!it!is!exposed!to!factors!such!as!
reactive! oxygen! species! (ROS),! plasmin! and! acid.! These! cause! the! associated!








targets! TGFβR1! and! smads2/3! for! degradation! via! the! ubiquitin! proteasome!
degradation!pathway.!!
!




prevents! their! degradation! by! increasing! expression! of! tissue! inhibitor! of!
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metalloproteinases!(TIMPs),!which! inhibit!matrix!metalloproteinases!(MMPs).! !The!
inhibitory! effect! of! TIMPs! on! MMPs! is! also! believed! to! promote! myofibroblast!
transformation.!
!








CTGF! (also! known! as! CCN2)! is! another! growth! factor! that! has! been! linked! to! the!
pathogenesis!of!renal!fibrosis.!!It!is a heparinNbinding!38NkDa!cysteineNrich!peptide!
matrixNcellular!protein!in!the!CCN!family!and!is!upregulated!by!TGFβ.!!It!modulates!
the!effects!of!many!growth!factors,! including!TGFβ.! !The! link!made!between!renal!
fibrosis! and! CTGF!was! first! shown! in! two! rat!models;! AntiNthy1! nephritis! and! the!
chronic!hypertension!model.!!In!the!AntiNthy1!nephritis!model!CTGF!expression!was!
seen! in! the! podocytes! and! mesangial! cells! prior! to! the! expression! of! αNSMA.!







upregulated! in! extracapillary! and! severe! mesangial! proliferative! lesions! of!
crescentic! glomerulonephritis! in! IgA! nephropathy,! focal! and! segmental!








cells! via! two! pathways:! the! Ras/MEK/ERK! pathway! and! the! canonical! SMAD!
pathway.!!Human!proximal!tubular!cells!(PTECs)!treated!with!TGFβ1!5ng/ml!for!24!
hours,! showed! a! 2N2.5Nfold! induction! in! CTGF.! ! Using! an! inhibitory! SMAD7!
overexpressing!cell! line,! they!were!able! to!demonstrate!with!a! luciferase!reporter!
assay! that! there! was! no! change! in! CTGF! promoter! activity! with! the! addition! of!
TGFβ1,! unlike! that! seen! with! wildNtype! (WT)! HKC! cells.! ! They! also! showed! no!
induction! of! CTGF! protein! in!HKC/SMAD7! cells!with! various! doses! of! TGFβ1! from!
(0.75N25ng/ml),! but! a! 5N6! fold! induction! in! protein! in! WT! HKC! cells,! thus!
demonstrating! that! SMAD! signalling! is! required! for! induction! of! CTGF! protein!
expression!by!TGFβ1! in!human!PTECs.! ! They!went!on! to! look!at! the!effect!of! the!
Ras/MEK/ERK1,2! pathway! on! TGFβ1Ninduced! CTGF! expression! and! showed! that!
ERK1,2!was!activated!in!both!WT!HKCs!and!SMAD7!overexpressing!cells.! !Both!the!
Ras! inhibitor! FTS! and! the!MEK! inhibitor! PD98059,! prevented! TGFβ1! induction! of!
CTGF!protein.!Inhibition!of!PI3!kinase!had!no!effect!(Phanish,!Wahab!et!al.!2005).!!!
 
In! 2011!Wang!et#al! looked!at! the! collaborative! role!of!CTGF!and!TGFβ! in# vivo,! as!
previous!data!had!all!been!derived! from!cell!culture!experiments.!They!concluded!
that!in!the!UUO!model!of!renal!fibrosis,!cooperation!of!both!cytokines!was!required!







The! insulinNlike! growth! factor! system! is! essential! to! the! normal! kidney! and! has!









flow!and!glomerular!filtration!rate!(GFR)!are!all! increased.! ! Interestingly,!the!same!




weight! as! they! grow! with! proportionately! small! kidneys.! ! Interestingly,! when!
treated!with! IGFNII,!kidney!size!was!significantly! improved!but! there!was!no!effect!
on!the!overall!weight!of!the!mouse!(Moerth,!Schneider!et!al.!2007).!!
!
Focusing! on! kidney! disease,! Miller! et# al# have! shown! a! role! for! IGFNI! in! renal!
regeneration!after!acute!tubular!necrosis!in!rats!(Miller,!Martin!et!al.!1992).!!In!early!
diabetic! kidney! disease,! renal! enlargement! occurs! due! to! a! combination! of!




cells! synthesise! IGFNI,! which! in! turn! stimulates! matrix! production! (Rabkin! and!









and! collagen! IV.! The! proteinuria,! hypertension! and! creatinine! clearance! all!






isoforms:! ETA! and! ETB.! ! In! a! healthy! environment! ETA! activation! stimulates!
vasoconstriction,!cell!proliferation!and!matrix!accumulation,!whereas!ETB!activation!
leads! to! vasodilation,! antiNproliferation! and! antiNfibrotic! outcomes! (Kohan! and!
Barton!2014).! !However! in!some!pathological!conditions!ETB!activation!can! lead!to!
tissue!injury.!!!
!
ETN1! signals! by! binding! directly! to! receptor! molecules,! in! both! an! autocrine! and!
paracrine!manner.!!One!of!the!key!roles!of!ET!in!the!healthy!kidney!is!the!regulation!
of! renal! sodium! and! water! excretion.! However,! ETN1! expression! is! increased! in!
diabetic!nephropathy;!it!affects!the!podocyte!cytoskeleton,!increases!apoptosis!and!
leads! to! podocyte! depletion! (Morigi,! Buelli! et! al.! 2006,! Kohan! and! Barton! 2014).!!
Zhou!et#al!showed!that!mesangial!cells!cultured!in!ETN1!0.1μM,!vasopressin!1.0μM,!
or! angiotensin! II! 1.0μM! demonstrated! partial! loss! of! FNactin! assembly! in! normal!
glucose.!!In!high!glucose!conditions!the!same!effect!was!seen!without!the!addition!
of!ETN1,!angiotensin!II!or!Vasopressin!(Zhou,!Hurst!et!al.!1995).!ETN1!is!up!regulated!
45Nfold! in! the! hypertensive! nephropathy! model! of! 5/6! nephrectomy! in! RenN2!
transgenic!rats!(transgenic!rats!that!had!a!mouse!renin!2!gene!inserted,!duplicated).!!
The!survival!rate!of!the!RenN3!transgenic!rats!deficient! in!the!RASS!machinery!was!
66%! (transgenic! rats! that!had!a!mouse! renin!3!gene! inserted,!duplicated).! !When!
these!mice! were! treated! with! ET! blocker! this! increased! the! survival! rate! to! 91%!
(Certíková!Chábová,!Vernerová!et!al.!2013).!!!!
!
Alongside! this! data! ET! antagonists! have! also! been! used! in! renal! patients.! ! In! a!
randomized! controlled! trial! in! type! 2! diabetic! kidney! disease! patients! with!
 39 
albuminuria! who! were! given! doses! of! an! anatagonist! (Avosentan)! between! 5N
50mg/d! or! a! placebo,! the! ET! antagonist! produced! a! 28.7N44.8%! reduction! in!
albuminuria!after!12!weeks!(Wenzel,!Littke!et!al.!2009).!!This!result!was!confirmed!
by!a!second!randomized!double!blind!placebo!controlled!study.! !This!study!looked!
at! patients! with! more! advanced! type! 2! diabetic! kidney! disease.! ! The! patients!
received! 25! or! 50mg/d! of! the! antagonist! or! a! placebo! alongside! an! ACEi! or! ARB.!
When!compared!with!placebo,!the!antagonist!gave!a!44.3%!or!49.3%!reduction! in!
the! urinary! albumin/creatinine! ratio! depending! on! whether! it! was! given! with! an!




The! reninNangiotensinNaldosterone! system! (RAAS)! plays! a! crucial! role! in! normal!
biological!function,!and!in!pathology!in!the!kidney.!Renin!is!secreted!into!the!plasma!
by! juxtaglomerular! cells.! ! It! then! circulates! to! the! liver! where! it! converts!
angiotensinogen!to!angiotensin! I,!which! is! later!converted!to!angiotensin! II!by!the!
angiotensin! converting! enzyme! located! in! the! lungs.! ! Angiotensin! II! affects! blood!
pressure!in!two!ways:!directly!as!a!peripheral!vasoconstrictor!and!by!stimulating!the!
production! of! the! hormone! aldosterone.! ! Aldosterone! stimulates! reabsorption! of!
sodium! and! water! in! the! distal! convoluted! tubule! causing! an! increase! in!
intravascular!volume!and!hence!blood!pressure.!!
!
Evidence! now! exists! to! suggest! that! angiotensin! II! could! also! play! a! role! in! renal!
fibrogenesis.! ! It! is! a! thousand! times!more! concentrated! in! the! kidney! than! in! the!
circulating! blood.! It! is! also! a! potent! vasoconstrictor! of! the! postNglomerular!





shown! to! induce!a! clear! reduction! in!proteinuria! in!patients!with! type!1!diabetes!
 40 
when! compared!with! BPNlowering! therapies! that! do! not! interfere!with! the! RAAS.!!
This!was! associated!with! a! lower! serum! creatinine! (Lewis,!Hunsicker! et! al.! 1993).!!
More! recently,! in! 2006! the! Bergamo! Nephrology! Diabetic! Complications! Trial!
(BENEDICT)! demonstrated! that! ACE! inhibitors! can! halve! the! development! of!




diabetic!patients! taking!an!ACE! inhibitor! (Ramipril)!with!proteinuric! renal!disease.!
Although!Ramipril!gave!good!BP!control,! treatment!resulted! in!a!slower!decline! in!
GFR! compared! with! placebo,! despite! equivalent! BP! control! (Jermendy! and!
Ruggenenti!2007).!
!
Angiotensin! II! has! also! been! linked! directly! to! the! pathogenesis! of! renal! fibrosis.!!
Angiotensin! II! type! 2! receptor! (AT2R)! deficient!mice! have! increased! renal! fibrosis!
compared!with!wild<type!mice.! !Sakai!et#al!hypothesised!this!might!occur! through!
the! regulation! of! fibrocytes,!which!were! also! upregulated! in!AT2RNdeficient!mice.!!
They!went!on!to!show!that!inhibition!of!the!AT2R!in!cultured!human!fibrocytes!led!
to! an! increase! in! angiotensin! IINstimulated! expression! of! type! 1! collagen.!!
Interestingly!when!angiotensin!II!type!1!receptor!(AT1R)!was!inhibited!in!the!same!
cell! type! there!was!a!decrease! in! collagen! synthesis,! leading! them! to!hypothesise!









Mammalian!notch!receptors!1N4!are!a! family!of! transmembrane!proteins! found! in!
all! metazoa.! ! Notch! is! recognised! to! play! a! role! in! cellular! development,!
differentiation,! survival! and! function.!All! notch! receptors!have!a!highly! conserved!
structure.! ! The! extracelluar! domain! (NECD)! includes! multiple! epidermal! growth!
factor! repeats! and! a! negative! regulatory! region! containing! the! notch/lin! domain.!!
The! intracellular! portion! has! one! or! two! nuclear! localisation! signals! and! several!
proteinNprotein!interaction!domains.!!Notch!can!only!signal!over!short!distances,!as!
it! requires! cellNtoNcell! contact! to! interact!with! its! ligands.! !Notch! signals!with! two!
families!of!ligands:!deltaNlike!(DII1N4)!and!jaggard!like!(Jag!1N2).!!When!notch!signals!
with!its!ligands!it!stimulates!a!proteolytic!series!of!events!that!causes!the!release!of!
the! intracellular! portion! of! the! protein,! which! is! subsequently! taken! up! into! the!
nucleus!and!induces!the!transcription!of!notch!target!genes.!
!
Notch! is! very! important! in! kidney! development.! ! It! has! been! shown! that! notch!
expression! is! critical! for! proper! nephron! endowment! to! occur;! low! nephron!
endowment!is!a!risk!factor!for!adult!onset!CKD.!!This!has!been!shown!by!the!use!of!
genetically! modified! mouse! models.! ! Activated! notch! is! highly! expressed! in!
tubulointerstital!fibrosis!in!patients!with!diabetic!kidney!disease.!!Susztak!et#al#have!





pathway.! ! The! Wnt! pathway! is! involved! in! regulating! cell! fate,! function! and!
phenotype.! ! It!plays!a! large! role! in! kidney!development.! ! The!Wnt! ligands!Wnt9b!
and! Wnt4! are! activated! during! kidney! development! and! in! turn! activate! the!
downstream! signalling! required! for! the! differentiation! of! mesenchymal! cells! to!
epithelial! cells,! forming! the! nephron.! It! has! been! shown! that! Wnt! signals! with!
 42 
stroma! cells! to! determine! the! elongation! and! differentiation! of! the! nephron!
(SchmidtNOtt!and!Barasch!2008).!!
!
It! is! now!becoming! clear! that!Wnt!plays! a! role! in! renal! fibrosis,! via! the! canonical!
Wnt! pathway.! ! The! canonical!Wnt! pathway! or!Wnt/βNcatenin! pathway! causes! an!
accumulation! of! βNcatenin! in! the! nucleus.! !Without!Wnt! signalling,! the! βNcatenin!
does!not!accumulate!in!the!cytoplasm,!as!it!is!degraded!by!the!destruction!complex.!!
The!destruction!complex! function!becomes!disrupted!by! the!binding!of!Wnt! to!Fz!
and! LRPN5/6,! causing! the! translocation! of! the! negative!Wnt! regulator,! Axin.! ! This!
inhibits!the!destruction!complex,!thus!allowing!βNcatenin!to!accumulate!and!localize!
to!the!nucleus!and!subsequently! induce!a!cellular!response!via!gene!transduction,!




and! βNcatenin! are! upregulated! in! the! tubules! and! interstitial! space! (Surendran,!
Schiavi!et!al.!2005,!He,!Dai!et!al.!2009).!!Duffield!et#al!have!gone!on!to!show!that!the!
Wnt! signalling! pathway! is! highly! upregulated! in! the! pericyte! as! it! transN
differentiates! into! the!myofibroblast,!which! they!have! seen! in!multiple!models!of!
renal! fibrosis! (Kawakami,! Ren! et! al.! 2013).! ! Kawakami!et# al! used! the!DkkN1! small!
molecule!to!block!Wnt!binding!to!the!coNreceptors!LRP5!and!LRP6!in!the!ischaemiaN
reperfusion! model.! ! This! treatment! showed! an! improvement! in! both! glomerular!







40Kda.! They! have! the! ability! to! function! as! molecular! switches,! transducing!
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upstream! signals! from! many! of! the! profibrotic! factors! discussed! above,! to!
downstream! effectors! and! have! been! implicated! in! the! pathogenesis! of! renal!
fibrosis.! ! As! such! they! are! potential! targets! for! antiNfibrotic! therapies! (Sharpe,!
Dockrell!et!al.!2000).!
!
Jennifer! Harvey! first! identified! HNRas! in! 1964! when! she! discovered! that! a! virus!
played!a!role!in!tumor!formation!in!mice!and!rats!(Harvey!1964).!!The!viral!gene!that!
caused! the! tumor! formation! was! named! Rat! sarcoma! or! Ras.! ! It! transpired! to!
encode!a!mutated!version!of!a!wildNtype!enzyme!that!had!intrinsic!GTPase!activity.!!
Later!work! revealed! the!presence!of!homologs!of!Ras! in!mammals.! ! Ras! isoforms!





Ras! is! the! founding!member! of! large! superfamily,! which! can! be! divided! into! five!
main! subgroups:! Ras,! Rho,! Rab,! Arf,! and! Ran.! They! are! categorised! based! on!
sequence!and! functional! similarities! (see! figure!1N2).! ! For!example,! the!Ras! family!
has! been! shown! to! regulate! gene! expression,! the! Rho! family! regulates! both!
cytoskeletal! reorganization! and! gene! expression! and! the! Arf! family! controls!
























































































































































and$ are$ encoded$ by$ different$ genes.$H;Ras$ and$N;Ras$ are$ expressed$ from$Hras%1'







targeting$ region$ ending$ in$ a$ CAAX$ box$ motif$ (where$ C=cysteine,$ A=any$ aliphatic$
ammino$acid$and$X$is$either$methionine$or$serine).$$The$CAAX$box$is$required$for$the$
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1.8.5 Post(translational(modifications(
Ras$ GTPases$ undergo$ multiple$ post;translational$ modifications,$ including$
prenylation$and$ubiquitination.$$
$




the$FPP$ intermediate$ can$be$ converted$ to$GGPP.$ $ Interestingly$H;Ras$ can$only$be$
farnesylated,$ whereas$ K;Ras4A,$ K;Ras4B$ and$ N;Ras$ can$ be$ farnesylated$ or$
geranylgeranylated.$ $ The$ Prenylation$ modifications$ target$ these$ proteins$ to$ the$
endoplasmic$ reticulum$ where$ the$ three$ terminal$ amino;acid$ residues$ (AAX)$ are$
subsequently$removed$by$endoprotease$(RCEI).$The$carboxyl$group$of$the$terminal$
cysteine$ then$ undergoes$ a$ further$modification$ and$ is$methyl$ esterified$ by$ ICMT$
(isoprenylcysteine$ carboxymethyltransferase).$ $ Following$ this$ N;Ras,$ H;Ras$ and$ K;
Ras4A$ are$ palmitoylated$ at$ another$ cysteine$ residue,$ upstream$ for$ the$ carboxyl$
terminus.$ These$ Ras$ GTPases$ are$ then$ transported$ to$ the$ plasma$membrane.$ K;
Ras4B$ however$ does$ not$ require$ this$ further$ modification$ and$ attaches$ to$ the$
plasma$membrane$ through$ its$ farnesyl$moiety$ and$polybasic$ lysine$ rich$ sequence$
(Zhang$and$Casey$1996,$Konstantinopoulos,$Karamouzis$et$al.$2007).$$$
 
Ras$ prenylation$ is$ a$ modification$ that$ is$ often$ targeted$ by$ cancer$ drugs,$ as$ the$
recruitment$ to$ the$ plasma$ membrane$ is$ crucial$ for$ Ras$ function$ inside$ the$ cell.$$
Researchers$have$investigated$the$use$of$farnesyltransferase$inhibitors$(FTIs),$which$
block$ farnesylation$ or$ geranylgeranyltransferase$ inhibitors$ (GGTIs),$ which$ block$
geranylgeranylation.$$Several$FTIs$were$tested$in$early$phase$clinical$trials$but$only$
Tipifarnib$and$Lonafarnib$went$through$to$phase$III$(Konstantinopoulos,$Karamouzis$
et$ al.$ 2007).$ $ Unfortunately$ the$ results$ showed$ the$ drugs$ to$ not$ be$ as$ useful$ as$




myeloma,$ breast$ cancer$ and$ pancreatic$ cancer.$ $ In$ a$ study$ by$ O’Dwyer$ et' al$ 8$
patients$ with$ a$ median$ age$ of$ 57$ years$ and$ a$ average$ of$ 4$ prior$ regimens$
underwent$a$phase$ I$ clinical$ trial.$ $They$were$ treated$with$varying$doses$of$GGTI;
2418$ from$ 120$ to$2060$ mg/m2/day.$ $ Each$ patient$ received$ a$ different$ dosing$
protocol.$The$patients$tolerated$the$drug$well$with$the$most$common$adverse$event$
observed$being$fatigue,$which$was$described$in$four$out$of$eight$patients,$further$to$






protein.$ $ This$ post;translational$ modification$ can$ control$ the$ abundance$ of$ the$
protein$and$subcellular$localization.$$The$ubiquitiantion$process$requires$three$types$






and$ PI3K$ than$ non;ubiquitinated$ Ras$ proteins,$ as$ ubiquitination$ increased$ GTP$






(GTP)$ or$ Guanosine$ diphosphate( (GDP)$ is$ bound.$ $ Switch$ I$ and$ Switch$ II$ motifs,$














RasGTPases$ have$ the$ ability$ to$ cycle$ between$ active$ and$ in$ active$ states,$ when$













binary$ complex,$ forming$ a$ tertiary$ complex,$ GEF;Ras;Nucleotide.$ $ Initially$ the$





again.$ $ This$ most$ commonly$ tends$ to$ be$ Ras;GTP$ as$ GTP$ has$ a$ much$ higher$
concentration$in$the$cell$than$GDP$(Wittinghofer$1998).$$$
$
In$ 1998$ Borlack;sjodln$ et' al' published$ evidence$ for$ the$ structural$ basis$ for$ the$
interactions$of$H;Ras$along$with$the$Ras$GEF,$son$of$sevenless$(SoS).$ $The$Ras;GEF$
SoS$ consists$ of$ two$ different$ alpha;helical$ structural$ domains:$ an$ amino;terminal$
domain$and$a$C;terminal$domain.$ $ The$C$ terminal$or$ catalytic$domain$ includes$all$











Ras$ GAPs$ have$ the$ ability$ to$ stimulate$ Ras$ to$ hydrolyse$ GTP$ to$ GDP,$ thus$
inactivating$Ras$signalling.$$Switch$II$has$the$DXXGQ$motif,$this$is$crucial$to$activate$











tyrosine$ kinases,$ G;protein$ coupled$ receptors$ and$ integrins.$ $ Receptor$ tyrosine$
kinases$ (RTK)$ are$ a$major$ family$ of$ cell$ surface$ receptors,$ which$ comprise$ of$ an$
extracellular$ domain$ containing$ the$ ligand;binding$ site,$ a$ transmembrane$domain$
of$ a$ single$ hydrophobic$ alpha$ helix$ and$ a$ cytosolic$ domain$ with$ tyrosine$ kinase$
activity.$ $ Their$ ligands$are$ soluble$proteins,$ such$as$ fibroblast$growth$ factor$ (FGF)$
and$platelet$derived$growth$factor$(PDGF).$$When$the$ligand$binds$to$its$receptor$it$
stimulates$ intrinsic$ tyrosine$ kinase$ activity$ of$ the$ cytosolic$ domain,$ causing$
downstream$ signal$ transduction.$ $ This$ process$ occurs$ in$ two$ stages.$ $ Stage$ one$
results$in$autophosphorylation$of$the$tyrosine$residues$in$the$lip$of$the$protein$near$
the$catalytic$site,$ leading$to$a$conformational$change,$which$allows$the$binding$of$




that$ have$ been$ shown$ to$ interact$ with$ the$ activated$ RTK$ sites.$ $ These$ adaptor$
proteins$ lack$ a$ signalling$ capability$ but$ act$ as$ a$ link$molecule$ in$ the$ transduction$
pathway$(Lodish,$Berk$et$al.$2000).$$
$
Tyrosine$ kinases$ signal$ to$ Ras$ by$ the$ help$ of$ the$ adaptor$ protein$ Grb2.$ $ Grb2$




to$ the$ plasma$membrane$where$ it$ is$ able$ to$ interact$with$ the$ Ras;GDP$molecule$
converting$it$to$Ras;GTP.$
$
The$ G;protein;coupled$ receptor$ (GPCR)$ family$ is$ the$ largest$ of$ the$ cell$ surface$
receptor$ families$ accounting$ for$ 2%$ of$ the$ total$ genes$ encoded$ by$ the$ human$
genome.$ $ They$ have$ seven$ membrane;spanning$ domains$ and$ are$ coupled$ to$
heterotrimeric$ GTPases.$ $ Heterotrimeric$ GTPases$ are$made$ up$ of$ three$ subunits:$
Gα,$Gβ$and$Gγ.$$Two$examples$of$G;protein$coupled$receptors$are$the$Angiotensin$II$
and$the$ET;1$receptors$(section$1.6.6).$$Both$of$these$receptors$have$been$shown$to$
signal$ independently$ and$ dependently$ of$ Ras.$ Binding$ of$ the$ ligand$ results$ in$ a$
conformational$change$of$the$G$protein,$in$turn$provoking$Gα$to$release$the$bound$
GDP$ and$ incorporate$ GTP.$ $ After$ the$ binding$ of$ GTP,$ the$ Gα$ subunit$ dissociates$
from$ the$ Gβγ$ subunit$ allowing$ them$ to$move$ freely,$ activating$ effector$ proteins.$$






GPCRs$ activate$ Ras$ via$ focal$ adhesion$ kinase$ (FAK)$ or$ Shc.$ $ These$ become$
phosphorylated$and$signal$downstream$to$Grb2,$which$binds$to$SoS,$using$the$SH3$





within$ their$ environment.$ $ The$ extracellular$ domain$ binds$ to$matrix$ components$
allowing$ them$ to$ influence$ cell$ adhesion,$migration$ and$ growth.$ $ As$ discussed$ in$
section$ 1.6.2$ integrins$ consist$ of$ alpha$ and$ beta$ subunits,$which$ interact$ to$ form$
binding$ pockets$ for$ extracellular$ matrix$ proteins.$ $ The$ cytoplasmic$ domains$ of$
integrin$ bind$ to$ cytoskeletal$ components,$ thus$ linking$ extracellular$ matrix$ to$
intracellular$ signalling$cascades.$ $ This$ form$of$ integrin$ signalling$ is$ called$ ‘outside;
 52 
in’,$ though$ integrins$ have$ also$ been$ shown$ to$ be$ activated$ in$ their$ intracellular$
section$allowing$them$to$signal$in$an$‘inside;out’$manner.$$It$has$been$hypothesised$
that$ changes$ in$ the$ interactions$ of$ the$ cytoplasmic$ tail$ results$ in$ a$ change$ in$ the$
physical$properties$of$the$receptor,$leading$to$increased$ligand;binding$affinity.$$Ras$













Ras$ and$ TGFβ1$ have$ a$ complex$ relationship;$ this$ has$ been$ especially$ shown$ in$
cancer$ research.$ $ For$ example,$ in$ 1992$ Mulder$ et' al' showed$ that$ TGFβ$ rapidly$
activates$ cytoplasmic$ Ras$ signalling.$ $ They$ demonstrated$ that$ both$ TGFβ1$ and$
TGFβ2$ can$ stimulate$ GTP;bound$ Ras$ in$ 3;6$ minutes$ in$ both$ intestinal$ and$ lung$
epithelial$cells.$ $They$concluded$that$due$to$the$speed$of$the$stimulation,$ it$was$a$





Ras/MEK/Erk$ pathway.$ $ They$ have$ demonstrated$ that$ TGFβ1$ has$ the$ ability$ to$
rapidly$activate$p44$MAPK$in$exponentially$proliferating$cultures$of$untransformed$
epithelial$ cells$ within$ 5;10$minutes$ of$ stimulation$ (Hartsough$ and$Mulder$ 1995).$$
This$data$was$different$to$that$described$by$Howe$et'al$who$showed$that$treatment$




caused$ the$ cell$ cycle$ arrest,$ suggesting$ that$ quiescent$ cells$ and$ growth$ factor;
stimulated$cells$respond$differently$to$TGFβ1$stimulus.$$$
$
As$ described$ in$ section$ 1.6.4$ TGFβ1$ can$ signal$ to$ CTGF$ in$ a$ Ras/MEK/ERK1/2$









Active$ Ras$ GTPases$ have$ the$ ability$ to$ stimulate$many$ signalling$ pathways,$ via$ a$
multitude$of$effector$proteins.$ $The$two$of$the$most$well$known$effectors$are$the$





been$ strongly$ linked$ to$ the$ pathophysiology$ of$ kidney$ disease.$ $ The$
serine/threonine$kinase$Raf$was$the$first$established$downstream$effector$of$Ras.$It$
interacts$with$Ras$GTP$ via$ the$Raf;binding$ domain$ (RBD)$ of$ Ras$ and$ cysteine;rich$
domain$(CRD)$of$Raf$(Mott,$Carpenter$et$al.$1996).$Once$associated$with$Ras,$Raf$is$
translocated$ from$ the$ cytoplasm$ to$ the$plasma$membrane.$ $ The$ activity$of$Raf$ is$
further$regulated$by$another$protein$called$14;3;3.$$This$protein$interacts$with$two$
phosphoserine$residues$located$in$the$amino;terminal$and$carboxy;terminal$of$the$
protein.$ $ Raf$ is$ kept$ in$ its$ inactive$ conformation$ by$ 14;3;3$ binding$ to$ both$ these$
phosphoserine$residues.$$Once$Raf$interacts$with$Ras$GTP$it$results$in$conformation$
change$ in$ the$ protein$ resulting$ in$ the$ release$ of$ protein$ 14;3;3$ from$ its$ amino$
terminus.$ Protein$ 14;3;3$ remains$ associated$ with$ Raf$ via$ its$ carboxy;terminal,$
facilitating$the$recruitment$of$other$proteins$(Rommel$and$Hafen$1998).$
$
Downstream,$ activated$ Raf$ phosphorylates$ and$ activates$ two$ mitogen;activated$
protein$kinase$kinases$(MAPKK)$known$as$MEK$1$and$MEK$2.$$MEK1$and$MEK2$act$in$
tandem$ phosphorylating$ two$ extracellular$ signal;related$ kinases,$ ERK1$ and$ ERK2.$













by$ many$ transmembrane$ receptors$ that$ have$ protein$ kinase$ cytosolic$ domains.$$
This$includes$members$of$the$insulin;like$growth$factor$(IGF)$family.$$Once$activated$






































































































































Ras$GTPases$are$well$ known$ for$ their$ role$ in$ cancer$but$ it$ is$ now$becoming$ clear$
that$they$also$play$a$key$role$in$chronic$kidney$disease.$$In$2000$Sharpe$et#al$showed$
that$ KARas4B$ is$ the$ predominantly$ expressed$ isoform$ of$ Ras$ in$ human$ renal$
fibroblasts$ in$ primary$ culture.$ HARas,$ NARas$ and$ KARas4B$ are$ also$ expressed$ to$ a$
much$ lower$extent$but$the$splice$variant$KARas4A$ is$not.$ $Sharpe$et#al$went$on$to$




assay$ they$ both$ reduced$proliferation$ equally,$ around$40%.$ $ They$ concluded$ that$
different$ isoforms$ may$ independently$ regulate$ proliferation$ by$ different$
downstream$ cascades$ (Sharpe,$ Dockrell$ et$ al.$ 2000).$ $ Interestingly,$ in$ a$ primate$
renal$ fibroblast$ cell$ line$ (Vero$ cells),$ only$ KARas$ inhibition$ reduced$ proliferation$
(Sharpe,$Dockrell$et$al.$1999).$$$
 
The$ role$ of$ Ras$ has$ also$ been$ examined$ in$ renal$ proximal$ tubule$ epithelial$ cells$
(PTECs).$In$2005$Phanish$et$al$showed$that$TGFβ1$induces$CTGF$expression$in$both$a$
Ras/MEK/Erk$ and$ SMAD$ dependent$ fashion,$ as$ describe$ in$ section$ 1.6.4.$ They$
further$ strengthened$ the$ link$ between$ Ras$ and$ TGFβ1$ by$ showing$ that$ NARas$ is$
required$ for$ TGFβ1$ autoinduction$ (See$ Section$ 1.8.10)$ (Dockrell,$ Phanish$ et$ al.$
2009).$$Other$groups$have$highlighted$HARas$as$the$most$important$p21$isoform$in$
TGFβAinduced$ EMT,$ via$ activation$ of$ the$ snail$ transcription$ factor$ (Peinado,$
Quintanilla$et$al.$2003).$$
 










isoforms.$ $ The$ proximal$ tubules$ predominantly$ expressed$ KARas$ whilst$ the$ distal$
tubules$ predominately$ expressed$ NARas.$ $ The$ interstitial$ cells,$ believed$ to$ be$
fibroblasts,$showed$expression$of$KARas$and$HARas,$but$not$NARas.$$There$appeared$
to$be$a$marked$change$in$Ras$expression$upon$disease.$$In$MGN,$podocytes$showed$




Removing$ the$Kras$ gene$ from$mice$ is$embryonically$ lethal$and$Kras$heterozygous$
mice$ have$ severe$ embryonic$ defects$ in$ the$ liver.$ As$ a$ result$ of$ this$ there$ are$ no$
publications$looking$at$Kras$knockouts$in$renal$disease$(Johnson,$Greenbaum$et$al.$








mice$ develop$ less$ renal$ fibrosis$ and$ reduced$ fibronectin$ expression$ (Grande,$
FuentesACalvo$ et$ al.$ 2010).$ $ From$ these$ knockout$mice$ they$have$ created$HrasA/A$
primary$ fibroblasts.$ These$ exhibited$ a$ higher$ basal$ phosphatidylinositolA3Akinase$
(PI3K)/Akt$ activation$ than$ wildAtype$ (WT)$ fibroblasts,$ whereas$ MEK/ERK$ 1/2$
activation$was$ similar$ in$both$ types$of$ cells.$ Surprisingly,$ fibronectin$ and$ collagen$
synthesis$were$higher$in$Hras−/−$fibroblasts$but$proliferation$was$lower$than$in$WT$
fibroblasts.$ $ The$ authors$ concluded$ that$ the$ absence$ of$ Hras$ resulted$ in$ lower$
proliferation$ which$ caused$ the$ reduction$ in$ fibrosis$ in$ the$ UUO$model$ (FuentesA
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Calvo,$ BlazquezAMedela$ et$ al.$ 2012).$ $ A$ similar$ effect$ was$ also$ seen$ in$ NrasA/A$
fibroblasts$(FuentesACalvo,$Crespo$et$al.$2013).$$
$
Our$ laboratory$ has$ shown$ that$ by$ treating$mesangial$ cells$with$ the$ Ras$ inhibitor,$




Folic$Acid$model$of$ renal$ fibrosis$ in$CD1$mice$that$ treatment$with$FTS$attenuated$
renal$fibrosis$(Bechtel,$McGoohan$et$al.$2010).$
$
As$ FTS$ has$ shown$ to$ have$ side$ effects$ in$ the$ cancer$ setting,$ some$believe$ that$ a$
more$specific$Ras$targeting$method$is$needed.$$Sharpe$et#al$showed$that$KARas$was$
the$key$isoform$in$the$proliferation$of$human$renal$fibroblasts,$as$inhibition$of$KARas$
negatively$ effected$ proliferation$ (Sharpe,$ Dockrell$ et$ al.$ 2000).$ $ This$ was$ taken$
further$by$Wang$et#al,$showing$that$KARas$inhibition$with$antisense$oligonucleotide$
(ASO)$ treatment$ attenuated$ renal$ fibrosis,$ in$ the$ UUO$ model.$ $ In$ this$ model$




a$ number$ of$ questions$ remain$ unanswered$ concerning$ the$ mechanism$ of$ this$





to$ the$ previous$ research$ undertaken$ in$ our$ lab$ they$ hypothesised$ that$ that$ the$
hypermethylation,$ and$ hence$ silencing$ of$ RASAL1$ was$ resulting$ in$ an$ overA
activation$of$Ras,$leading$to$a$fibrotic$response.$$This$finding$was$further$examined$
in$ the$ oneAhit$ chronic$ folic$ acid$ model$ of$ renal$ fibrosis,$ in$ which$ they$ gave$ one$
250mg/kg$ dose$ of$ folic$ acid$ to$ CD1$ mice$ and$ left$ the$ model$ to$ progress$ for$ 6$
 60 
months.$ $ They$ had$ two$ treatment$ groups.$ One$ treated$ with$ 5iAazacytidine$ (a$









not$allow$ isoform$specific$ inhibition.$ $The$ lack$of$specificity$of$FTS$ for$a$particular$






no$ commercially$ available$ small$molecules$ for$ targeting$ KARas$ in$ a$ highly$ specific$
manner.$ $ The$ concept$ of$ targeting$mRNA$has$ long$ been$ thought$ of$ as$ a$ possible$
therapy$ for$disease;$ the$ two$most$ common$methods$being$RNA$ interference$and$
antisense$ oligonucleotides$ (ASO).$ $ ASO$ have$ been$ used$ widely$ in$ research$ since$
1970$(Wang,$Newbury$et$al.$2012,$Yu,$Watts$et$al.$2013,$Noveck,$Stroes$et$al.$2014).$$











unachievable$ goal$ for$ most$ conventional$ pharmacological$ agents.$ Isis$
Pharmaceuticals$ specialise$ in$ ASO$ chemistry$ and$ drug$ discovery.$ $ They$ have$





methoxyAethyl$ modified.$ $The$ central$ 10$ sugars$ remain$ as$ deoxyribonucleotides$
resulting$ in$ increased$stability$and$RNA$affinity$ (Hendry$and$Sharpe$2003,$Sharpe,$
Wang$et$al.$2008).$$
$
Isis$ have$ undertaken$ in$ depth$ biodistrubution$ studies$ using$ the$ Isis$ ASO$ 104838,$
deigned$ to$ target$ TNF$ alpha.$ $ These$ studies$ were$ carried$ out$ in$ Monkey,$ dog,$
mouse$ and$ rat.$ $ On$ analysis$ of$ the$ plasma$ post$ IV$ administration,$ plasma$
concentration$showed$that$the$distribution$profile$decreased$rapidly$in$a$polyphasic$
manner$ in$ mouse$ and$ rat$ whereas$ in$ monkey$ and$ dog$ it$ showed$ a$ monoA
exponential$ decline.$ $ Nevertheless$ IV$ administration$ exhibited$ relatively$ rapid$
distribution$to$the$tissues$in$all$species,$with$an$estimated$halfAlife$of$between$15$to$










On$ comparison$ of$ different$ species$ differences$ and$ similarities$ were$ seen.$$
Increased$ ASO$ dosing,$ monkey$ and$ dog$ showed$ increased$ distribution$ rates$
 62 
however$ interesting$ in$ mice$ increased$ doses$ appeared$ to$ saturate$ the$ process$
resulting$in$slower$distribution$of$ASO.$$They$also$demonstrated$that$there$was$no$
accumulative$effect$of$ASO$and$there$was$no$difference$ is$alternant$dosing$versus$
dosing$ once$ every$ four$ days.$ $ Equivalent$ body$ weight$ to$mass$ doses$ resulted$ in$
higher$uptake$ in$ the$monkey$ compared$ to$ rodents.$ $ The$ASO$showed$a$ low$ level$









This$ introduction$ has$ summarized$ what$ is$ known$ about$ the$ pathophysiology$ of$
renal$fibrosis$and$has$presented$a$body$of$evidence$to$highlight$a$possible$role$for$
KARas$ in$ this$ process.$ Previous$ work$ within$ the$ lab$ has$ shown$ that$ antisense$
oligonucleotides$ targeting$ KARas$ can$ prevent$ renal$ fibrosis$ in$ the$ UUO$ model.$


























tubule,$ originally$ derived$ from$ a$ Brinster$ transgenic$mouse$ [Tg(SV4OE)Bri7].$ $ The$
Brinster$ transgenic$mouse$ contains$ the$ large$ T$ antigen$of$ SV40$ virus,$making$ the$






Proximal$ tubule$ cell$ lines$ were$ grown$ in$ DMEM/F12$ (1:1)$ medium$ (Life$
Technologies)$ supplemented$ with:$ hydrocortisone$ (50nm),$ penicillin$ (100U/ml),$
streptomycin$ (100μg/ml)$ (PAA,$ GE$ Healthcare$ LTD,$ Buckinghamshire,$ UK),$
amphotericin$ (250μg/ml)$ and$ Insulin$ Transferin$ Selinate$ (ITS)$ (Gibco,$ Life$
Technologies)$ to$ 1X$ concentration.$ $ Kidney$ fibroblast$ cell$ lines$ were$ grown$ in$
DMEM$(Gibco,$Life$Technologies)$supplemented$with$10%$FCS,$penicillin$(100U/ml),$
streptomycin$ (100μg/ml)$ and$ amphotericin$ (250ug/ml)$ (PAA,$GE$Healthcare$ LTD).$$
In$experiments$requiring$transfection,$antibiotics$were$removed.$$$
$
All$ cell$ lines$ were$ routinely$ grown$ in$ 75cm2$ flasks$ (Corning$ Life$ sciences)$ and$
experiments$conducted$in$35mm,$60mm$or$10cm$dishes$(Corning$Life$sciences,$New$
York,$USA).$The$cells$were$incubated$in$Techne$incubators$at$37oC$in$95%$CO2$and$
5%$O2.$ $ Upon$ passaging$ the$ cells,$ the$medium$was$ removed,$ and$ the$ cells$ were$











DNA$ synthesis$was$ assessed$ by$ Bromodeoxyuridine$ (BrdU)$ incorporation.$ BrdU$ is$
taken$ up$ into$ the$ genomic$material$ of$ proliferating$ cells$ as$ they$ pass$ through$ SA
phase$and$DNA$duplication$takes$place.$Cells$were$plated$onto$35mm$dishes$in$their$
standard$ growing$medium.$ After$ 24$ hours,$ the$medium$was$ removed;$ cells$were$
washed$once$with$PBS$ then$ incubated$ in$ low$ serum$conditions$ (0.5%FCS)$ for$ the$
following$24$hours.$The$medium$was$changed$to$low$serum$medium$supplemented$






antibody$ (SigmaAAldrich)$ at$ a$ dilution$ of$ 1$ in$ 100$ in$ blocking$ solution$ was$ then$
added$and$cells$were$incubated$at$4°C$overnight.$Cells$were$then$washed$with$PBS$
before$ being$ incubated$ with alexafluor$ 555$ goat$ antiAmouse$ antibody$ (at$ a$ final$
concentration$of$5μg/ml)$at$ room$temperature$ in$ the$dark$ for$30$minutes.$Finally$
cell$nuclei$were$counterstained$with$Hoechst$33342$at$a$concentration$of$10μg/ml$
for$ 15$ minutes$ at$ room$ temperature$ in$ the$ dark$ before$ being$ visualized$ with$ a$







(LDH)$ release$ from$ cultured$ cells.$ Cells$ were$ seeded$ in$ 96$ well$ plate$ in$
quadruplicates$at$a$density$of$5000$cells$per$well$in$normal$growing$medium$for$24$
hours.$The$cells$were$washed$and$replaced$with$ low$serum$medium$of$150μl$and$
left$ for$ a$ further$ 24hr.$ At$ that$ stage$ 50μl$DMEM$FA12/20%$FCS$ +/A$ TGFβ1$4x$ the$
concentration$ to$ be$ tested$was$ added$ to$ each$well$ and$ the$ cells$ incubated$ for$ a$
further$ 24$ hours.$ LDH$ activity$ was$ then$ assessed$ using$ the$ Promega$ Cytotox$ 96$







Maximum$ LDH$ release$was$ determined$ by$ addition$ of$ lysis$ buffer$ to$ one$well$ of$
untreated$cells$45$minutes$prior$to$reading$the$assay.$Endogenous$LDH$activity$from$






paraformaldehyde$ in$ PBS$ pH$ 7.4$ for$ 15$min$ at$ room$ temperature.$ $ The$ samples$
were$then$washed$twice$with$ice$cold$PBS.$$Incubate$the$samples$for$10$minutes$in$
PBS$containing$0.25%$Triton$XA100$(or$100$μM$digitonin$or$0.5%$saponin).$Triton$XA
100$ is$ the$most$popular$detergent$ for$ improving$ the$penetration$of$ the$antibody.$
Wash$cells$three$times$PBS.$$Incubate$cells$with$1%$BSA$in$PBST$for$60$min$to$block$
unspecific$ binding.$ $ Incubate$ cells$ with$ the$ AQP1$ antibody$ (diluted$ in$ 1%$ BSA$ in$
PBST)$overnight$at$4oC.$$Decant$the$solution$and$wash$the$cells$with$PBS$3$X$5$min.$$






in$ the$ dark.$ $ Decant$ the$ solution$ and$ wash$ the$ cells$ with$ PBS$ 3$ times$ 5$ min.$







reAsuspended$ in$10ml$of$growing$medium.$ $Cell$number$was$counted$using$a$x$ to$
work$ out$ total$ cell$ number.$ $ The$ cells$ were$ pelleted$ and$ reAsuspended$ to$ a$
concentration$of$30,000$cells/ml$ in$10%$FCS$DMEM.$$60,000$Vero$cells$(2ml)$were$







MPTECs$ grown$ to$ 90%$ confluence$ in$ 75cm2$ flasks,$ they$ were$ trypsinised$ and$
suspended$ in$ 10ml$ of$ optiMEM$ (Life$ Technologies)$with$ no$ antibiotics.$ $ 500μl$ of$
cells$were$mixed$with$400μl$of$transfection$mix$described$section$Error!+Reference+
source+not+ found.,$and$transferred$into$35mm$dishes$for$RNA$extraction$or$scaled$
up$ 2X$ to$ 60mm$ dishes$ for$ protein$ extraction.$ $ Growing$ medium$ containing$ no$
antibiotics,$was$added$to$a$final$volume$of$2ml$or$4ml$respectively.$$After$24hr$the$











In$ the$ adapted$ chronic$ folic$ acid$ model$ employed$ in$ this$ study,$ eightAweek$ CD1$





To$ reduce$ animal$ death$ the$ folic$ acid$ dose$ was$ reduced$ from$ 250mg/kg$ to$
125mg/kg.$$The$model$timeframe$spans$either$85$or$112$days.$
$
The$ animals$ were$ housed$ in$ groups$ of$ four$ or$ five$ mice$ only$ being$ separated$ if$
necessary$ for$ animal$welfare.$ $ The$mice$ received$ standard$ feed$and$water$ad1lib,$































































































































































































































































































































The$mouse$was$ safely$ restrained$by$ grasping$ firmly$ at$ the$base$of$ the$ tail.$ $ $ This$
form$of$ resistant$was$used$ for$moving$ the$mouse$over$ short$ distances.$ The$mice$









shoulders$ and$ used$ to$ quickly$ grasp$ the$ scruff$ of$ the$ neck,$ resulting$ in$ the$mice$
unable$to$rotate$and$allowing$the$ injection$to$be$given$ in$the$scruff$of$ the$mouse$
using$a$insulin$needle.$$



















Transfection$ of$ the$ antisense$ oligo$ nucleotides$was$ done$ using$ Lipofectimine$ LTX$
(Life$Technologies).$$MPTECS$were$transfected$using$a$reverse$transfection$protocol.$$










The$ CD1$mice$ were$ injected$ subcutaneously$ under$ the$ scruff$ of$ the$ neck$ or$ the$
flank. 
2.7 Unilateral+Ureteric+Obstruction+–+Wistar+Rats+













a$ facemask$ and$ concentration$ was$ reduced$ 2A2.5%$ for$ maintenance$ and$ oxygen$
flow$rate$was$reduced$to$0.5A2ml/min.$$
 
Procedure:$ Under$ anaesthesia$ the$ abdominal$ region$ was$ cleaned$ using$
chlorhexidine$solution.$A$midline$incision$was$made$using$aseptic$technique$and$the$




ties$ to$ cause$ obstruction.$ The$ ureter$ was$ NOT$ cut.$ Abdominal$ contents$ were$
replaced$ and$ incision$ was$ reAsutured$ in$ two$ stages$ using$ a$ deep$ muscle$ layer$
continuous$ suture$ followed$ by$ a$ continuous$ skin$ suture.$ Buprenorphine$ was$
administered$subcutaneously$(s/c)$at$a$dose$of$30µg/kg.$Any$first$dose$of$treatment$







Blood$ samples$ were$ taken$ from$ the$ mice$ at$ both:$ sacrifice$ points$ via$ cardiac$
puncture$and$at$different$ time$points$during$model$progression.$ $ In$ live$mice$ the$
mice$were$first$heated$in$a$heating$chamber$28oC,$to$allow$for$dilation$of$the$blood$
vessels$(making$sure$the$mice$were$not$in$distress).$Blood$was$taken$from$the$tail$or$
foot$ vein$ using$ a$ needle$ to$ pierce$ the$ skin$ and$ collected$ in$ to$ 500μl$ tubes.$ $ The$
blood$ samples$ were$ subsequently$ spun$ at$ 4000g$ to$ pellet$ the$ blood$ cells.$ $ The$









assay$was$conducted$as$per$ the$manufactures$ instructions,$ in$brief:$5μl$of$diluted$
sample$was$pipetted$in$to$a$96$well$plate$along$with$the$standards$provided.$$$150μl$
of$Urea$mix$was$ added$ to$ each$well,$mixed$ and$ incubated$ for$ 15$minutes$ at$ RT.$





from$ the$ body.$ $ Creatinine$ is$ a$ byproduct$ of$ muscle$ metabolism.$ $ Creatinine$ is$
removed$primarily$by$glomerular$filtration,$but$also$by$proximal$tubular$secretion,$
there$ is$ little$ tubular$ reabsorption$ of$ creatinine.$ When$ the$ kidney$ is$ damaged,$
creatinine$is$not$filtered$effective,$resulting$in$creatinine$levels$in$the$blood$to$rise.$$
Creatinine$ levels$ in$ blood$ can$ be$ used$ to$ calculate$ estimated$ GFR$ (eGFR).$$




Collagen$ is$ one$ of$ the$ main$ components$ of$ the$ extracellular$ matrix$ and$ was$
measured$using$the$QuickZyme$total$collagen$assay.$$The$QuickZyme$total$collagen$
assay$ is$ based$ on$ the$ detection$ of$ hydroxyproline.$ Hydroxyproline$ is$ a$ nonA$
proteinogenic$amino$acid,$which$in$mammals$is$found$both$in$elastin$and$collagen.$
Its$ presence$ is$ mainly$ limited$ to$ the$ triple$ helix$ of$ collagen,$ where$ its$ presence$




The$ samples$were$ assayed$ as$ per$ the$manufactures$ instructions.$ $ In$ brief$ frozen$

































1.5ml$ Eppendorf$ using$ tweezers.$ $ The$ plasmid$ was$ reAsuspended$ in$ 100μl$ of$ TE$







eukaryotic$ cells$do$not$have$ the$ability$ to$ replicate$ circular$DNA$only$express$ the$
genes$encoded$in$the$plasmid.$$Chemically$competent$E.$coli$JM109$cells$were$used$
as$ for$ plasmid$ replication.$ $ The$ competent$ cells$ were$ defrosted$ on$ ice$ for$ 10$






medium$ containing$ no$ antibiotics$ was$ added$ to$ the$ cells,$ which$ were$ then$
incubated$at$37oC$in$a$shaking$incubator$for$60$minutes.$$The$cells$were$then$plated$
on$Agar$plates$containing$Kanamycin$at$a$concentration$of$50μg/ml.$$The$cells$were$
diluted$ at$ 1/100,$ 1/10$ or$ neat$ with$ LB.$ $ The$ plates$ were$ placed$ in$ an$ incubator$
overnight$ at$ 37oC$ to$ allow$ single$ colonies$ to$ grow.$ $ The$ following$ day$ one$ single$
colony$ was$ picked$ and$ grown$ in$ Luria$ Broth$ containing$ kanamycin$ overnight$
(50μg/ml)$ in$10ml$cultures.$ $The$plasmids$were$purified$ from$these$cultures$using$
the$E.N.Z.A$mini$prep$II$(Omega$BioAtek$GA,$USA).$$$
$












For$RNA$extraction$ from$Adherent$Cells$ the$medium$was$ first$ aspirated$ from$ the$
dish$and$the$cells$washed$twice$with$PBS.$$The$PBS$was$then$completely$removed.$
As$ per$ the$ manufactures$ instructions,$ 350μl$ RLT$ lysis$ buffer$ was$ added.$ A$ cell$
scraper$was$used$to$detach$cells$from$the$dish$in$a$methodical$pattern.$$The$RLT$cell$
mixture$ was$ then$ transferred$ to$ a$ 1.5ml$ tube,$ vortexed,$ then$ passed$ through$ a$
QIAshredder$ (Qiagen)$ to$ complete$ cell$ lysis.$ $ The$ flow$ through$was$ collected$ and$
passed$ through$ the$ RNAeasy$ spin$ column.$ $ Wash$ steps,$ as$ per$ manufacturers$
 80 
instructions,$ followed$ this$ and$ finally$ the$RNA$was$eluted$with$RNAseAfree$water.$$
The$RNA$was$stored$at$A80oC.$
2.11.2 Tissue+samples+
All$ glassware$ and$ equipment$ was$ treated$ to$ ensure$ it$ was$ RNaseAfree:$ It$ was$
submerged$in$sodium$hydroxide$solution$(NaOH$solution$0.1mM)$for$60$minutes$at$
room$temperature$followed$by$1mM$EDTA$for$a$further$60$minutes.$$After$this$they$
were$ treated$ with$ 0.1%$ diethypyrocarbonate$ (DEPC)$ water$ overnight.$ The$





in$ 500μl$ of$ TRI$ reagent.$ $ Once$ homogenized$ a$ second$ 500μl$ of$ TRI$ reagent$ was$
added$and$the$sample$was$mixed$via$inversion.$$500μl$of$sample$was$transferred$to$
a$fresh$1.5ml$tube$and$stored$at$A80$oC$for$future$RNA$extractions.$$To$the$remaining$
aliquot,$ a$ further$ 500μl$ of$ TRI$ was$ added,$ mixed,$ and$ incubated$ on$ ice$ for$ 5$














The$top$ layer$ is$ the$aqueous$phase,$which$contains$the$RNA.$ $The$middle$ layer,$ is$
the$interphase$or$white$buffy$coat$layer,$this$contains$the$genomic$DNA.$200μl$was$
pipetted$from$the$aqueous$phase$into$a$clean$1.5ml$tube$and$200μl$of$70%$ethanol$




seconds$ at$ 12,000g$ The$ flow$ through$was$ discarded.$ $ 500μl$ buffer$ RPE$was$ then$
added$ to$ the$ RNeasy$ spin$ column,$ and$ centrifuged$ for$ 1$minute$ at$ 12,000g.$ The$
flow$through$was$discarded.$$To$remove$excess$liquid$from$the$column$it$was$spun$







Qiagen,$ 82840865).$ $ Oligo(dT)$ primers$ are$ a$ popular$ choice$ as$ they$ have$ high$
specificity$ for$mRNA$and$ allow$many$different$ targets$ to$ be$ studied$ from$a$ large$
pool$of$cDNAs.$However,$OligoAdT$primers$always$initiate$reverse$transcription$from$
the$ 3´$ end$ of$ the$ transcript$ at$ the$ polyA$ tail.$ $ This$ can$ lead$ to$ difficulties$ in$
application$if$the$RNA$has$secondary$structures.$$The$second$kit$used$was$the$RNA$
to$cDNA$high$capacity$kit$(Applied$Biosystems,$life$technologies).$$This$kit$uses$both$
random$ octamers$ and$ oligo$ dTA16.$ $ Random$ primers,$ have$ the$ ability$ to$ bind$ all$
along$ the$ mRNA$ resulting$ in$ increased$ cDNA$ yield.$ $ However,$ to$ avoid$
overestimating$CT$values$it$is$best$to$use$them$in$parallel$with$Oligo$dTs.$$$
2.12.1 +Omniscript+


















Real$ Time$ Quantitative$ PCR$ has$ numerous$ strengths$ over$ traditional$ semiA
quantitative$ methods$ allowing$ detection$ of$ as$ little$ as$ a$ twoAfold$ difference$ in$






target$ cDNA$ is$ copied,$ the$ probe$ (which$ binds$ downstream$ from$ the$ forward$
primer)$ is$ broken$ down$ by$ 5’$ A$ 3’$ exonuclease$ activity$ of$ Taq$ polymerase.$ This$
releases$ the$ reporter$ from$ the$ quencher$ allowing$ detection$ of$ fluorescence$ from$
the$FAM$dye.$$The$level$of$fluorescence$released$is$used$to$quantify$the$amount$of$





Each$ sample$was$ tested$ in$ triplicate$on$a$384$well$QPCR$plate.$ $ Each$ target$ gene$
was$compared$to$an$endogenous$control,$normally$GAPDH.$$The$Primer$Probe$mix$






1.$Master$mix$$ $$5$ 1X$ 5N$
2.$Primer$Probe$$ 0.5$ 250nM$ 0.5N$
3.$Water$$ 2.5$ A$ 2.5N$
4.$cDNA$ 2$ A$ A$
$












house$keeping$gene$and$ subtracts$ it$ from$ the$ cycle$ time$value$post$ threshold$ for$
the$ target$ gene,$ called$ the$ [delta$ Ct].$ $ This$ number$ is$ then$ used$ to$ compare$
between$ experimental$ conditions,$ your$ [delta,$ delta$ Ct].$ $ This$ method$ enables$





used$ as$ the$ African$ Green$ Monkey$ is$ yet$ to$ be$ sequenced.$ The$ human$ taqman$
primers$probes$were$first$tested$to$confirm$their$ability$to$amplify$cDNA$from$Vero$
cells.$ $When$testing$the$collagen$primer$probes,$only$the$collagen$IV$primer$probe$
showed$ good$ amplification,$ therefore$ Collagen$ IV$ was$ the$ collagen$ quantified$ in$


































































Protein$ concentrations$ were$measured$ using$ the$ BCA$ Pierce$ Protein$ colorimetric$
assay$ (Thermo$ Scientific).$ This$ is$ a$ twoAcomponent,$ highAprecision,$ assay$ reagent$
set$to$measure$total$protein$concentration$compared$to$a$protein$standard.$$Firstly$
10μl$ of$ protein$ samples,$ at$ concentrations$ ranging$ from$neat$ to$ a$ 1$ in$ 8$ dilution$
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were$ pipetted$ in$ duplicate$ into$ a$ 96$well$ plate$ alongside$ protein$ standards.$ $ The$
protein$standards$ranged$from$0mg/ml$to$2mg/ml.$$Assay$buffer$A$was$mixed$with$
assay$buffer$B$at$a$ ratio$of$40:1$ resulting$ in$a$green$solution.$ $200μl$of$ the$green$
solution$was$added$to$each$well$and$the$plate$was$sealed$and$incubated$at$37oC$for$
20$minutes.$$On$incubation$with$protein$this$buffer$turns$from$green$to$purple.$$The$
absorbance$ of$ each$ well$ was$ measured$ with$ a$ plate$ reader$ (A562nm).$ $ The$
concentration$of$samples$was$calculated$using$the$standard$curve,$generated$from$






Due to relatively low abundance of Ras within the cell, detection on western 
blot analysis using total lysate is often difficult.  To overcome this, Ras was 
concentrated from protein lysates using immunoprecipitation. The total 
protein concentrations of cell lysates were assayed as above and equal 
amounts of total protein (0.1–0.5 mg) from each sample were used.  All 
volumes were normalised to 1ml with PBSTDS.  15µl of anti-Ras-agarose 
conjugate (anti-v-H-Ras rat monoclonal antibody (Y13-259) agarose 
conjugate (OPO1A), Calbiochem) was added per ml volume and all samples 
were left rotating at 4oC overnight. Samples were then centrifuged at 2,500xg 
at 4oC for 3 minutes and the supernatant discarded. The pellets were then 
washed again in 1ml of PBS then again centrifuged as above.  The pellets 
were re-suspended in 20µl 2-3X western sample buffer containing 10% 2-
mercaptoethanol and heated to 100oC for 3 minutes.  The agarose beads 
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were removed by pulse centrifugation and 15µl of final supernatant was used 











and$ the$ stacking$ gel.$ $ The$ resolving$ gel$ (bottom$ part)$ allows$ the$ proteins$ to$
separate$ according$ to$ their$ size,$ whereas$ the$ stacking$ gel$ (top$ part)$ clusters$ the$




1ml$ of$ water$ was$ gently$ placed$ on$ top$ and$ the$ gel$ was$ allowed$ to$ set$ for$ 45$
minutes.$ $ Once$ set,$ remove$ the$ water$ from$ the$ gel$ and$ dry$ with$ filter$ paper.$$
Immediately$ fill$ the$ remainder$ of$ the$ cast$with$ stacking$ gel$ and$ insert$ the$ comb.$$





Resolving gel solution (20ml): 
 Resolving Gel 
(ml) 10% 12% 15% 




6.7 8.0 10.0 
1.5M Tris (pH 
8.8) 
5.0 5.0 5.0 
10% SDS 0.2 0.2 0.2 
10% ammonium 
persulfate 
0.2 0.2 0.2 
TEMED 0.008 0.008 0.008 
 
5% Stacking gel solution (10ml): 
Water    6.8ml 
30% acrylamide mix 1.7ml 
1M Tris (pH 6.8)  1.25ml 
10% SDS   0.1ml 
10% ammonium persulfate 0.1ml 
TEMED   0.01ml 
$
2.15.5 +Electrophoresis++
The$ set$ gel$ was$ placed$ into$ the$ central$ casket$ of$ the$ running$ apparatus$ and$ the$
inner$ chamber$ was$ filled$ with$ electrophoresis$ running$ buffer.$ $ The$ comb$ was$
removed$ from$ the$ gel$ and$ the$ protein$ samples$ (prepared$ as$ described)$ were$
loaded.$Alongside$ these$samples$a$biotin$ ladder$and$colour$markers$were$ loaded.$$
The$ central$ casket$ was$ then$ carefully$ placed$ into$ the$ electrophoresis$ running$
chamber$ and$ the$ outer$ space$ was$ filled$ with$ electrophoresis$ buffer.$ The$ lid$ was$






Three$ layers$of$blotting$paper$were$placed$on$ the$gel$ and$on$ the$opposite$ side$a$
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square$ of$ nitrocellulose$membrane$was$ added,$ followed$ by$ three$more$ layers$ of$
blotting$paper.$ $The$sandwiched$blotting$paper,$gel$and$membrane$was$put$ inside$
sponges$socked$in$Towbin$buffer$inside$a$plastic$cassette.$$The$cassette$was$placed$
in$ a$ chamber$ between$ the$ electrode$ plates$ with$ the$ gel$ facing$ the$ negative$
electrode$and$the$membrane$next$to$the$positive$electrode.$$The$chamber$was$filled$













a$ further$ three$ 10$ minute$ washes$ in$ PBST,$ membranes$ were$ developed$ using$ a$
chemiluminescence$ECL$Prime$system$(GE$Healthcare$Amersham$and$subsequently$
exposed$to$XAray$film$for$5$seconds$to$15$minutes.$$The$films$were$quantifiable$by$















Gapdh$ Mouse$ 10%$Milk$ Millipore$ Ma3374$ 1/10000$
HSP70$ Goat$ 10%$Milk$ Santa$Cruz$ SC1060$ 1/1000$
Total$ERK$ Rabbit$ 5%$BSA$ Cell$
Signaling$
4695$ 1/5000$
pERK$ Rabbit$ 5%$BSA$ Cell$ $4370$ 1/5000$
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Signaling$
α$SMA$ Rabbit$$ 10%$Milk$ Abcam$ Ab5694$ 1/500$
KARas$ Mouse$ 10%$Milk$ Calbiochem$ OP24$ 1/2000$
IPAPan$Ras$ Mouse$ Na$ Calbiochem$ OP40$ 15µl$






All$ tissues$ samples$ collected$ at$ the$ point$ of$ sacrifice$ were$ SnapAfrozen$ in$ liquid$
nitrogen$ and$ stored$ at$ A80oC$ until$ required,$ or$ fixed$ in$ 40%$ neutral$ buffered$
















































16$ Water$2nd$flush$reagent$ Every$cycle$ Drain$
$
This$ process$ dehydrates$ the$ tissue.$ $ The$ tissue$was$ then$ embedded$ into$ paraffin$
and$4µm$sections$were$cut$on$a$rotor$microtome$(Reichert$Jung$2030)$to$give$thin$
and$ even$ sections$ of$ tissue.$ $ The$ sections$ were$ floated$ on$ to$ a$ water$ bath$
(Raymond$A$Lamb$mounting$water$bath)$to$help$even$them$out.$$The$samples$were$
then$placed$on$to$either$polylysine$or$glass$sides.$$The$samples$were$fixed$by$placing$




One$ method$ of$ matrix$ assessment$ in$ this$ project$ was$ the$ use$ of$ special$ stains$
(Chromatin).$$Chromatic$stains$have$many$benefits$such$as$ease$of$stain$$
2.17.1 +Haematoxylin+and+Eosin+(H&E)+Stain:+
H&E$ staining$ allows$ basic$ tissue$ structure$ to$ be$ seen$ using$ light$microscopy.$ The$
haematoxylin$binds$to$the$nuclei$in$the$cell,$whilst$the$eosin$acts$as$a$counterstain$
to$help$differentiate$between$the$cytoplasm$and$other$structures$in$the$tissue.$$$

















minutes$ then$picroAsirius$Red$solution$ for$120$minutes$and$washed$ in$0.5%$acetic$




Picromallory$ Trichrome$ (PMT)$ is$ a$ special$ stain$ that$ can$ be$ used$ to$ visualize$ the$
degree$of$fibrosis$present$in$tissue$samples,$by$using$collagen$as$a$surrogate$marker$
to$ quantify$ fibrosis.$ $ It$ uses$ three$ different$ dyes$ to$ highlight$ different$ tissues.$$
Collagen$is$highlighted$in$blue$by$aniline$blue,$red$blood$cells$in$yellow$by$ponceau$
fuchsin$ and$ fibrin$ $ appears$ red$ (picroAorange).$ $ The$ three$ dyes$ are$ used$ in$ size$






Dewax$&$ rehydrate$ tissue;$ Celestine$ BlueAhaematoxylin$ sequence;$wash$ and$ blue$
sections$ in$ running$water;$ rinse$ in$70%$ industrial$methylated$spirit;$ stain$ in$PicroA
Orange$(10$minutes);$rinse$in$distilled$water;$stain$with$Ponceau$fuchsin$ (2$ min);$






Masson’s$ trichrome$ is$ similar$ to$ that$ of$ picromallory$ trichrome,$ as$ it$ uses$ three$
dyes,$hence$the$term$‘trichrome’.$$The$three$dyes$are:$Weigert’s$iron$haematoxylin,$
Ponceau$ fuchsin$ and$ light$ green$ to$ differentiate$ between$ nuclei,$
muscle/cytoplasm/erythrocytes$and$collagen$respectively.$$The$kit$for$this$stain$was$




Immunohistochemistry$ (IHC)$ utilises$ specific$ antibodies,$ whether$ whole$ or$
fragments$ and$ can$ be$ done$ by$ two$ methods:$ direct,$ requiring$ one$ antibody$ or$




Vector$ Labs$ ImmPRESS$ Peroxidase$ Polymer$ Detection$ System$ (Mouse:$MPA7402$;$
Rabbit:$ MPA7401$)$ uses$ a$ twoAstep$ IHC$ staining$ technique$ involving$ polymers$
conjugated$ with$ secondary$ antibodies.$ $ This$ allows$ further$ amplification$ of$ the$
signal$ compared$ with$ standard$ secondary$ antibody$ techniques$ allowing$ smaller$






Bake$ Slides$ overnight$ at$ 45oC,$ Deparafinize:$ Xylene$ (three$ times)$ (4$ minute$ per$
solution);$ the$ samples$ were$ then$ rehydrated$ in$ three$ graded$ ethanols,$ for$ 3$
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TrisEDTA$pH9$buffer$ in$ the$pressure$ cooker$on$hot$plate$ at$ 120oC,$ lid$on$but$not$




















Dilute$ 30%$ hydrogen$ peroxide$ 1$ in$ 10$ with$ methanol,$ to$ make$ a$ 3%$ hydrogen$
peroxide$solution.$ $Place$ the$slides$on$ the$slide$ rack$and$draw$wax$circles$around$
the$tissue$sample$with$a$wax$pen$(Dako).$$Cover$the$tissue$with$H202$for$10$minutes.$
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Remove$ liquid$ from$ the$ slide$ and$ incubate$ in$ the$ second$ antibody$ A$ ImPRESS$













Dehydrate:$ The$ samples$ were$ then$ rehydrated$ in$ three$ graded$ ethanol’s,$ for$ 30$


































































































































































































































































































































































microscopy# and# quantified# using# software.# # Bright# light# microscopy# was# used# to#




screen#print#of# the#software.# #To#quantify# the#slides#both#the#automated#measure#






this# information,# click# store#data# (number#4).# # To#measure#another# section#of# the#
slide# move# the# slide# to# a# new# area,# then# press# the# refresh# button# to# the# left#
(number#5)#then#repeat#stages#3#and#4.###
#
By# using# the# data# collected# from# this# software,# area# coverage# can# be# calculated.##
Prior# to# quantifying# the# slides# they# were# blinded# by# another# user,# to# remove#
possible#bias.###
2.19.2 **Blinding*
All slides were blinded prior to quantification.  Another scientist, labeled the slides 
with different numbers in a random order.  The key remained with the other 










The# threshold# for# staining#was# set# per# batch# by# eye.# # In# some# instances# this#was#








































RNaseAfree# protocol# for# glassware:#Wash# glassware# thoroughly.# Incubate# in# 0.1M#
sodium#hydroxide#solution#for#1#hour#at#room#temperature.#Rinse#in#DEPC#treated#
water.# Incubate# in# 1mM#EDTA# solution# for# 1# hour# at# room# temperature.# Rinse# in#
DEPC#treated#water.#
#






























1%#Aniline#blue# in#1%#acetic# acid:# 2g#aniline#blue,#2ml#acetic# acid,# 200ml#distilled#
water.#
#
Celestine# blue# haemalum# sequence:# Dewax# and# rehydrate# sections.# Stain# in#










































It# is# characterised# by# large# amounts# of# tubular# dilatation# and# tubulointerstitial#
fibrosis.##One#drawback#of#this#model#is#the#absence#of#biochemical#endpoints#such#
as# creatinine#and#BUN,#due# to#one# remaining# functioning#kidney.# # This#model#has#
also# been# shown# to# be# particularly# inflammatory,# making# it# hard# to# distinguish#
between# drugAinduced# inflammation# (inflammation# caused# by# the# drug,# as#








of# renal# function#within# 30#days# (Yang,# Zuo# et# al.# 2010).# # The# lesserAused# chronic#
folic#acid#model#was# first#described# in#1973#by#Schubert#et#al# followed#by#a#more#
recent# publication# in# 2010# by# Bechtel# et# al.# # Schurbert# et# al# used# a# variable# and#
somewhat# aggressive# folic# acid# dosing# regime,# in# some# instances# administering#
more#than#eight#doses#of#250mg/kg#folic#acid#to#the#same#animal.##This#resulted#in#a#
high# mortality# rate# and# would# not# be# appropriate# or# permissible# under# modern#
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home#office#regulations#(G.#E.#Schubert,#K.#Welte#et#al.#1973).#Bechtel#et#al#adapted#
the#model# to#give#a#single,#high#dose#of#250mg/kg#of# folic#acid#at# the#start#of# the#
model#and#allowed#it#to#progress#for#6#months.# #This#protocol#was#also#associated#
with#a#relatively#high#animal#death#rate#in#the#acute#phase,#and#the#chronic#phase#










was#administered.# #To#reduce#animal#death,# the# folic#acid#dose#was#reduced#from#
250mg/kg#to#125mg/kg.# #The#model#time#frame#spans#either#85#or#112#days.# #This#
chapter# discusses# the# characterisation# of# this# model# examining# a# number# of#
biological#markers#of#CKD#at#the#following#time#points:#day#0,#35,#58,#85,#112.#
 
Figure# 3A1# shows# the# schematic# diagram# of# the# CFAN#model# (as# described# above#



















































































































































To# monitor# the# health# of# the# mice# and# progression# of# the# model,# mice# were#
weighed#periodically#throughout#the#85#or#112#days.##This#weight#data#is#depicted#in#
Figure#3>2.#In#the#85#day#model#(shown#in#graph#I#of#Figure#3>2)#at#day#3#and#day#24#
there#were# significant#weight#drops# in# the#CFAN#mice# compared#with# the#healthy#




gain# between# the# two# groups# occurred# at# a# similar# rate.# # In# the# 112# day# model#
(Graph# II)# a# similar# pattern# of# weight# change# was# seen,# with# significant# drops# in#
weight#at#day#3#and#day#23#after# the# folic#acid# injections,# followed#by# recovery# in#






that#Ras#GTPases#play#a#major#role# in#the#development#of#renal# fibrosis.# #Previous#
models#have#shown#changes#in#the#three>p21#isoforms#at#mRNA#and#protein#levels#
and#in#protein#activation.##Levels#of#mRNA,#protein#and#protein#activation#states#of#
H>Ras,# K>Ras# and# N>Ras# were# therefore# measured# over# the# course# of# the# CFAN#
model.#Figure#3>3#shows#the#changes#in#mRNA#levels#of#H>Ras#(Top),#K>Ras#(middle)#




increase# at# D112# in# CFAN# mice# compared# with# healthy# controls.# # N>Ras# mRNA#







Depicts! the!change! in!weight!of! the!CFAN!and!normal!mice!during! the!study!at!85!
days!(graph!I)!and!112!days!(graph!II)!!
Statistical!Analysis:!TDtest!.*p<!0.05!Error!Bars!SEM.!!! !
























































































(Graph! I)! HDRas! mRNA! expression! normalized! to! GAPDH.! (Graph! II)! KDRas! mRNA!




























































































































D35 # # ######## ###### #




















K>Ras# protein# expression# and# activation# was# also# examined# in# CFAN# mice# and#









mice#at# this# time#point.# #By#day#85,# there# is#a#clear# increase# in#active>Ras# in#CFAN#




To# see# if# activated# Ras# is# a# signalling# via# the# MAP# Kinase# pathway,# pERK# was#
examined# by# both# western# blot# and# IHC.# # Figure# 3>6# shows# normalized# protein#
expression# of# pERK# and# total# ERK# at# day# 56# and# day# 85.# # There# was# clear# pERK#
expression# in# the# CFAN# samples# and# normal# samples.# # Using# densitometry# to#
analyse#the#bands,#when#the#OD#values#were#normalized#to#total#ERK#no#significant#
differences#(Anova,#Tukey)#were#observed#between#CFAN#and#normal#mice#(Figure#
3>7# I).# # Although# the# analysed# protein# samples# had# been# normalized# using# a# BCA#
protein#assay,# these#samples#demonstrated# large#changes# in# total#ERK#expression.##
To#see# if#this#pattern#of#expression#was#correct#pERK#was#also#analysed#using# IHC.##
Figure# 3>7# II# shows# IHC# of# pERK# at# day# 85,# 4μm# paraffin# sections# were# cut# and#
stained#with#pERK#antibody#as#described#in#section#2.18#and#Table#2.3..##There#was#








































































































































































































































(Graph' I)' Quantification' of' pERK'Western' blot' (blot' shown' in' Figure' 3>6),'White'
column='control'mice,'Spotted'column'='CFAN'mice.''Column'1'–'Day'0,'columns'2'
&' 3' >' Day' 56' and' columns' 4' &' 5' >' Day' 85.' ' Statistical' Analysis:' T>Test' (each'
timepoint)'–N.S.' ' (Image' II)'p>ERK' IHC'of'4μM'FFPE'kidney'sections,' showing' that'




































The" CFAN"model" has" both" acute" and" chronic" stages" and" Figure" 398" gives" a" visual"
indication" of" the" changes" occurring" in" the" kidney" during" the" acute" phases" of" the"
model." "Folic"acid"causes"damage"to"the"kidney"via"both"direct"toxicity"and"crystal"
formation" inside" the" tubules" (Yang," Zuo" et" al." 2010)." " Examination" of" the" CFAN"
kidneys"under"bright"light"revealed"large"areas"of"tubule"dilation,"while"observations"













(Images' I)' 4μM' FFPE' kidney' sections' from' a' CFAN' mouse' 48hr' post' folic' acid'
injection,' Shown' under' bright' light' (Left)' and' under' cross>polarized' (Right)' 200X'
magnification.' (Images' II)' Full' sections' from' CFAN'mice' 48hr' post' first' injection.''
CFAN'(left),'Normal''(right).''
' '

























As" described" in" the" introduction," the" progression" of" CKD" is" characterised" by"
increased"scar" tissue"or" fibrosis" in" the"kidney." "Fibrosis"has"been"shown"to"be" the"
histological"marker" that" correlates"best"with"changes" in" renal" function." " The"main"
constituent" of" fibrosis" is" collagen," in" the" kidney" this" is" usually" type" I" and" type" III"
collagen"and"both"are"well9established"markers"of"kidney"fibrosis.""
"
To"measure" levels" of" collagen" in" this" study"multiple"methods"were" used." " Figure"
3910" shows" the" special" stains," picro9sirius" red" (PSR)" and" two" different" trichrome"




The" H&E" staining" in" Figure" 3910" was" performed" on" paraffin" embedded" kidney"
sections"and"undertaken"as"described" in" section"2.17.1." " The" stain" showed" tubule"
atrophy" and" increased" nuclei" at" all" time" points," which" worsened" with" model"
progression." " The" increased"nuclei" could"be"due" to" an" increase" in"proliferation"of"
interstitial"cells"or"due"to"inflammatory"infiltrates.""The"areas"of"damage"were"seen"




















The" collagen" stains" were" viewed" with" light" microscopy" and" quantified" using" NIS"
elements" software." " Figure"3911"depicts" the"quantification"of" the" stained" samples"
from" Figure" 3910" " In" the" PSR" samples" there"was" 13%" collagen" at" day" 85" in" CFAN"




was" used." " Hydroxyproline" is" a" derivative" of" collagen," formed" after" hydrolysis" of"




























Quantification' of' collagen' using' the' PSR' (Graph' I)' and' Trichrome' (D85' –' Picro'
mallory' Trichrome,' D112' –'Masson' Trichrome).' (Graph' II)' Shown' in' Figure' 3>10.!!
Normal'control'mice'–'White'columns'with'circles,'CFAN'mice'–' spotted'columns'















































Figure! 3)12! Collagen! mRNA! quantification! in! CFAN! mice! and! quantification! of!
protein!levels!of!hydroxylproline!!
(Graph' I)' mRNA' quantification' of' collagen' 1a' at' D35' (left' 2' columns)' and' D112'
(right'2'columns).''(Graph'II)'hydroxyproline'quantification'of'total'collagen,'Shows'
day' 85' model' (left)' and' day' 112' model' (right).' ' Normal' control' mice' –' White'
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The"origin"of"myofibroblast"was"discussed" in"detail" in" the" introduction." "Although"
the"origin"of"the"myofibroblast" is"an" interesting"question," in"our"model" I"am"more"
interested"in"the"absence"or"presence"of"the"myofibroblast.""The"best"marker"of"the"











IHC" was" undertaken." " 4μm" FFPE" kidney" sections" were" stained" with" anti9 α9SMA"
antibody"as"described"in"2.18,"with"the"parameters"in"Table"2.3.""The"samples"were"
counterstained"with"PSR"to"see"if"α9SMA"was"seen"in"the"interstitium"of"the"kidney.""










The' above' figure' shows' protein' levels' of'αSMA' (with'GAPDH' internal' control)' in'
normal' and' CFAN'mice' at' days' 56,' 85' and' 112.' The' gels' in' the' left' column' are'



















stained' using' Dab' substrate' shown' in' brown' (arrows' highlighting' staining),'










To" confirm" the" mice" were" developing" kidney" dysfunction" I" used" two" markers:"




Figure" 3915" (I)" Shows" creatinine"measurements" in" normal"mice" (day" 0)" and"CFAN"
mice"(D85).""By"day"85"the"creatinine"is"6"times"that"of"Day"0."(p=0.05)""Figure"3915"





Figure! 3)15! Assessment! of! Renal! function! in! CFAN! mice! (creatinine! and! urea!
measurements)!
(Graph'I)'Creatinine'measurement'of'normal'mice'at'day'0'and'CFAN'mice'at'D85,'
white' column' with' circles' represents' normal' sample' of' creatinine' taken' at' D0;'
spotted'column'with'squares'represents'creatinine'measurements'of'CFAN'mice'at'
D85.''Statistical'Analysis:'Test'p=0.05'SEM'
(Graph' II)' Urea'measurement' at' D0' in' normal'mice' (white' columns'with' circles),'










































































mice." " By" day" 85" there"was" a" clear" increase" in" total9Ras" activation" in" CFAN"mice"
compared" to" normal." " This" correlates" with" the" changes" of" K9Ras" mRNA" (100%"




Western" blot" analysis" of" pERK" and" total9ERK," showed" no" up9regulation" of" pERK,"
however"there"was"large"changes"in"total9ERK"in"normalized"protein"samples"raising"
questions"of"the"appropriateness"of"the"control.""PhosphoERK"was"expressed"in"the"








I" have" demonstrated" that" the" up" regulation" in" K9Ras" and" active" total9Ras" both"
correlate"with"increase"collagen"deposition.""All"three"kidney"compartments"showed"
a" similar" induction" of" collagen;" when" focusing" on" cortex" only," there" was" 12%"




the" cortex" to" the" medulla," often" localising" around" blood" vessels" or" glomeruli.""






















do" produce" a"more" variable" phenotype" due" to" their" own" natural" variation." " This"
results"in"larger"‘n’"numbers"being"needed"to"reach"statistical"significance"and"needs"
to"be" justified"against" the"principles"of" the" three"Rs." " I"would"argue" that" the"data"










In" this" model," the" AKI" causes" abrupt" loss" of" kidney" function," resulting" in" the"
retention"of"urea"and"other"nitrogenous"waste"products"and"in"the"dysregulation"of"
extracellular"volume"and"electrolytes."This"processes"was"originally"believed" to"be"








for" unnecessary" animal" death," which" has" been" described" with" the" use" of" higher"
doses"of"folic"acid.""
"















be" later" used" to" test" the" effect" of" K9Ras" inhibition" on" renal" fibrosis" and" function.""
Prior" to" this," this" chapter" describes" the" characterisation" of" the" K9Ras" targeting"
therapy"(AIM"2)."
"
To" target"K9Ras" in" this" study"we"have"used"antisense"oligonucleotides" (ASO)." "Our"
lab"has"had"a" long9standing"collaboration"with" Isis"Pharmaceuticals,"a" specialist" in"
antisense" drug" discovery," who" have" provided" us" with" six" ASO" to" target" K9Ras" in"










followed!by! the! coding! region! containing! the!nucleotides! in! red!and!purple.! ! The!
red!nucleotides!encode!the!N!terminus,!(highly!homologous!region!between!all!Ras!
































































Using" screening" data" provided" to" us" by" Isis" Pharmaceuticals," depicting" the"
knockdown"efficiency"of"the"six"ASO"in"hepatocytes,"three"ASO"were"subsequently"
screened" in# vitro" in" kidney" cells." " The" three" ASO" were" screened" in# the" mouse"





different" transfection" methods" available" including" chemical" and" electroporation"
transfection"methods." " In" this" study" the"MPTECs" initially" proved" to" be" difficult" to"
transfect"and"did"not"give"reproducible"results"using"a"forward"transfection"method"
with" lypofectamine" LTX" and" plus" reagent" (life" technologies)" (data" not" shown).""
Subsequently" a" reverse" transfection" method" was" utilized" with" the" chemical"
transfection" reagent" LTX" &" plus" reagent." " The" ASO" 487143," ASO" 487080" and"
ASO487166" were" transfected" at" concentrations" of" 100nmol" and" 200nmol.""
Alongside" these"ASO,"a" transfection" reagent9only" control," a" control,"non9targeting"
oligo" and" an" N9Ras9targeting" ASO" were" tested" as" controls" for" transfection" and"
specificity." "24"hours"after"transfection"the"cells"were"harvested"for"both"RNA"and"
protein"extraction"as"described"in"section"2.11.1"and"2.14.1.""QPCR"was"performed"





Graph" I" shows" QPCR" data" of" K9Ras" mRNA" fold" change" in" all" treatment" groups"
described" above." The"most" effective" K9Ras" knockdown" (50%)"was" seen"with" both"
ASO487080" and" ASO478143" at" 100nmol" and" 200nmol" respectively." " The" control"
non9targeting" ASO" had" no" effect" on" K9Ras" mRNA" at" either" 100nmol" or" 200nmol"
concentrations.""The"N9Ras"ASO"had"no"off9target"effects"on"K9Ras."Graph"II"and"III"
shows" the" effect" of" the"K9Ras"ASO"on"H9Ras" and"N9Ras" respectively." "Neither" the"
control" oligo" nor" the" three" K9Ras" ASO" had" a" significant" effect" on"H9Ras"mRNA" at"
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either" 100nmol" or" 200nmol" concentrations," however" the" control" oligo" did"
significantly"reduced"N9Ras"expression"at"200nmol"concentrations.""The"N9Ras"ASO"




after"ASO" treatment,"K9Ras"protein"was"also"analysed" in" cell" experiments." " Figure"







To" assess" the" toxic" effect" of" the" reverse" transfection" of" ASO" in" MPTEC" a" Lactic"
Dehydrogenase" activity" assay" (LDH)" was" undertaken." " An" LDH" assay" measures"
release" of" LDH," which" is" a" stable" cytosolic" enzyme" that" is" released" upon" cell"




In" conclusion" both" ASO080" and" ASO143" gave" suitable" K9Ras" knockdown" in# vitro.""







transfected! with! vehicle! (Black! column),! Control! Oligo,! KCRas! targeting! ASO! 143,!












































































































































































Western! blot! analysis! of! PAN! Ras! IP! samples! probe! with! KCRas! Ab.! ! Group! 1! =!
protein!lysates!from!MPTECs!stimulated!with!5ng/ml!TGFβ1!and!Control!Oligo!and!
Group!2!=!protein! lysates! from!MPTECs! stimulated!with!5ng/ml!TGFβ1!and!KCRas!
ASO143.!!Left!=!24hr,!Right!=!120hr!postCtransfection!extraction.!!!
'!! !









ASO! 080,! 143! and! 166,! NCRas! targeting! ASO! at! 060! and! Control! Oligo! at!






















































To" test" the" efficacy" of" K9Ras" knockdown" in# vivo,# the" ASOs" were" administered" to"
either" C57Bl/6" or" CD1" mice," with" the" same" dosing" protocol." " Mice" weighing"
between" 30940" grams" were" given" ASO" dissolved" in" saline" at" a" dose" of" 20mg/kg"
every" other" day" for" six" days," with" the"mice" being" sacrificed" on" day" 7." " RNA"was"
extracted" from" the" snap9frozen"kidney" samples"of"CD1"mice"using" the" tissue"RNA"
extraction" method" in" section" 2.11.2" and" reverse" transcribed" using" Ominscript"
Reverse9Transcriptase" (Qiagen)." "Dr"Ayesha" Irtiza9Ali"undertook" the"ASO" testing" in"





induced" adequate" knockdown," ranging" between" a" 45955%" (white" bars)." " ASO"
487080"(ASO080)"induced"the"best"knockdown"at"55%,"closely"followed"by"487143"
(ASO143)"and"487166"(ASO166)" that"gave"a"knockdown"of"45%"as"compared"with"
















Graph! I! Shows!KCRas!mRNA!expression.! ! The! left! half! of! the!Graph! shows! results!
from!C57Bl/6! (undertaken!by!Dr!Ayesha! IrtizaCAli)! and! the! right,! the! results! from!
CD1! mice.! ! The! light! grey! columns! represent! the! vehicleCtreated! mice,! with! the!
white!columns!highlighting!the!ASO!that!gave!knockdown!above!45%!and!the!black!






















































































































































In" this" thesis" the" use" of" a" control" oligo" will" be" used" in" future" experiments" to"
compare" the" targeting"K9Ras"ASO." " In"past" studies" control" oligos"have"highlighted"
problems"with"toxicity;"therefore"the"screening"protocol"for"this"oligo"uses"a"larger"
dose"than"that"used"for"the"K9Ras"targeting"ASO.""The"control"antisense"was"given"to"
CD1"mice"at"a"dose"of"100mg/kg/week" for"a" three9week"period" (non"control"ASO"
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To"understand"where" the"ASO"accumulates"within" the"kidney," its"distribution"was"
examined" both" in" fibrotic" conditions" (UUO" samples" taken" from" previous" and" in"
normal"CD1"mice.""
"
4μm" serial" sections" of" formalin" fixed" paraffin" embedded" kidney" samples" were"
obtained"from"a"study"by"Dr"Joe"Wang," looking"at"the"role"of"K9Ras"ASO"in"Wistar"











condition" are" described" in" Table" 2.3." " AQP1" is" a"marker" of" proximal" tubules" and"
AQP2" is" a"marker" of" collecting" ducts." " The" top" image" of" Figure" 497" shows" AQP1"
staining" in" brown" (DAB" substrate)," the" staining" localized" to" the" proximal" tubules.""
The" middle" image" depicts" ASO" staining" in" brown" and" the" bottom" shows" AQP2"
staining"in"brown,"the"staining"localizes"to"the"collecting"ducts.""The"light"blue"circles"




in" healthy" CD1" mice" shown" in" the" right" column." " The" tubules" labeled" P" stains"
positive"for"the"proximal"tubule"marker"AQP1"and"negative"for"the"collecting"duct"
marker"AQP2." " The" same" tubule" is" also" positive" for"ASO." " The"opposite"was" seen"
with" collecting" duct," C." Shows" that" the" ASO" is" taken" up" mainly" in" the" proximal"
tubule"in"these"models."
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Figure"498" shows"4μm"kidney" sections" from"CFAN"kidneys"depicting" three"distinct"
patterns"of"ASO"distribution.""All"three"patterns"were"seen"within"the"same"kidney.""
The"kidney"in"this"figure"was"taken"from"a"12"week"CFAN"mouse"treated"with"K9Ras"











highest"uptake"seen" in" the" liver"and"kidney"with"a" tissue" to"plasma"concentration"
ratio" of" 20:1" and" 80:1" respectively," after" 2" h" (Sands," Goreyferet" et" al." 1994)." " To"








!Figure' 4)7'Antisense' localisation'with' fibrotic' tissue' (left)' and' normal' CD1'mice'
(right)'
IHC!of! three! serial! 4μM!FFPE!kidney! sections.! !Wistar! rat!obstructed!kidney! (left)!
and! normal! CD1!mice! (right).! ! The! top! sections! are! stained!with! an! antibody! for!
AQP1!(brown!substrate),!the!middle!sections!are!stained!with!ASO!antibody!(brown!









































The" kidneys" from" mice" treated" with" the" most" effective" ASO" (487080," 487166,"
487143)" were" further" examined" at" a" histological" level" to" look" for" signs" of"
inflammation." " Two" additional" ASO" were" included" in" the" experiment" describe" in"
section"4.4.1"in"CD1"mice.""These"ASO"have"been"used"in"previous"experiments;"one"
caused" interstitial" inflammation" in"Wistar"rats"and"the"other"did"not." "The"kidneys"
from"these"animals"acted"as"comparative"samples"for"the"new"ASOs"under"test."
"
On"examination"of" the"H&E" staining" shown" in" Figure"4910" there"were"no" signs"of"
inflammatory" infiltrates" within" the" kidneys" from" animals" treated"with" any" of" the"
three"new"ASOs,"interestingly"there"were"also"no"signs"of"inflammation"in"the"ASO"
that" had" shown" to" be" inflammatory" in" rats." " To" confirm" this" CD3" staining" was"


















CD3! immunohistochemistry! of! 4μm! FFPE! Kidney! sections! from! CD1!mice! treated!





















Isis" Pharmaceuticals" provided" us" with" six" K9Ras" ASOs," which" had" previously"









between" the" three9p21" isoforms." " However" Isis" Pharmaceuticals" have" found" that"
targeting" 3’UTR" region" is" highly" effective" at" giving" an" efficient" knockdown.""












control" oligo" treatment" at" either" concentration." " On" analysis" of" N9Ras" expression"
there"was"no"change"at"either"concentrations" for" the"K9Ras" targeting"ASO"treated"
cells" but" the" control" oligo" did" reduce" N9Ras" expression" at" the" 200nmol"
concentration."""The"effect"of"control"oligo"on"N9Ras"was"not"seen"in"later"in#vitro"or"














differing" efficiency" of" each" ASO" or" it" could" be" due" to" the" efficiency" of" the"
transfection" protocol." " As"mentioned" previously"MPTECs" proved" to" be" difficult" to"
transfect" in" this" study"meaning" a" reverse9transfection" protocol" was" subsequently"
used.""The"reverse9transfection"method"has"been"previously"used"in"our"laboratory"
to"transfect"cells"that"are"difficult"to"transfect,"however"it" is"not"a"perfect"solution"





assayed" in" the" medium" of" cells" treated" with" the" ASO." " The" highest" toxicity" was"
shown"with"ASO143"and"ASO166,"however" these"ASO"still" showed" toxicity"of" less"





The" six" ASO" given" to" us" by" Isis" Pharmaceuticals" were" all" screened" in# vivo.# # The"
reason" for"screening"all"ASO" in#vivo# is"because"the"efficiency"of" the"ASO"does"not"
always"match"the"in#vitro"data."""The"ASO"were"analysed"in"either"in"CD1"or"C57bl6.""
All" screening" protocols" showed" that" ASO" 487080," ASO" 487143" and" ASO" 487166"
were"effective" at" knocking"down"K9Ras," giving" a" knockdown"of" greater" than"45%.""
Interestingly,"some"ASO"showed"better"knockdown"in#vivo"than"in#vitro,"though"this"
may"be" influenced"by"the"efficiency"of"the"transfection"protocol." "As" in"the" in#vivo"
setting" ASO" are" SC" injected" into" the" mice" and" freely" filtered" by" the" glomeruli,"
although"we"do"not"know"the"exact"method"of"uptake"of"the"ASO"in"the"kidney"we"




gene" therapy" using" antisense" oligonucleotides" or" small" interfering" RNAs" has"
previously" been" described" as" gene" silencing," implying" that" complete" loss" of"
expression" is" necessary" (Sharpe," Wang" et" al." 2008)." " However" we" feel" this" is" a"
unnecessarily" ambitious" target" in" treating" a" complex" pathophysiological" process"
such"as"fibrosis.""Fibrosis"is"closely"related"to"wound"healing,"meaning"that"by"simply"
reducing" levels"of"overactive"Ras"back"to"those"seen" in"healthy"animals," it"may"be"
sufficient"to"flip"the"switch"from"a"pro9fibrotic"phenotype"to"healing"and"resolution"
phenotype." " This" is" particular" important" when" discussing" a" target" such" as" K9Ras,"








The"use"of" an" appropriate" control" oligo" for" a" specific"ASO" is" a" controversial" topic"







is" not" inflammatory" in" these" mice." " The" control" oligo" was" only" received" in" the"











The" antisense" shows" different" localisation" in" the" kidney." " In" some" places" it" binds"
strongly" to" the"brush"borders"of" the"proximal" tubules." "This"could"be"because" the"
ASO" stays" trapped" here" for" a" longer" period" of" time" before" entering" the" blood"
stream" so" one" cannot" rule" out" the" possibility" that" it" is" an" artifact" of" the" staining"
procedure." " In" other" areas" strong" dense" tubular" staining" was" seen," this" mostly"












also" detected" in" the" liver" and" spleen." " As" the" liver" plays" a" major" role" in" drug"
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metabolism"it"is"not"surprising"there"is"a"large"uptake"of"ASO"in"these"samples.""This"









being" used" in" rodents" are" purely" for" proof" of" principle" of" the" effect" of" target"
knockdown.""If"K9Ras"targeting"becomes"a"real"therapeutic"option"in"human"disease,"
new"human"ASO"will" be"designed" and" their" inflammatory" activity"will" need" to"be"








ability" to" become" prenylated," preventing" them" from" binding" to" the" plasma"
membrane,"thereby"affecting"its"function"in"the"cell.""Researchers’"have"investigated"
the" use" of" farnesyltransferase" inhibitors" (FTIs)" or" geranylgeranyltransferase"
inhibitors"(GGTIs),"which"block"the"activation"of"all"Ras"isoforms.""Several"FTIs"have"
been" tested" in" early" phase" clinical" trials" but" only" Tipifarnib" and" Lonafarnib" went"
through"to"phase"III"trials"(Konstantinopoulos,"Karamouzis"et"al."2007).""The"results"
from"the"later"trials"were"not"as"positive"as"expected,"with"patients"reporting"side"
effects." " GGTIs" have" demonstrated" a" good" anti9proliferative" effect" in" animals"









2010)." "The"reservation"of"using"targeting"FTS"as"a" treatment" in"CKD" in"humans" is"
the" possible" side" effects," which" have" been" noted" by" cancer" patients." " In" cancer"
treatment" side" effects" can" be" accepted" as" the" treatment" normally" only" spans" a"
short" period" of" time," but" in" a" chronic" disease" such" as" CKD" the" therapy"might" be"





to" make" a" small" molecule" isoform9specific," due" to" the" structural" similarities"



























analysed," along" with" a" normal" control" group" in" which" mice" received" sodium"
bicarbonate" instead" of" the" two" folic" acid" injections" (Normal" control)." " The" CFAN"
mice" who" had" received" folic" acid" injections" were" treated" with" either:" saline"
injections"as"a"control"for"ASO"(referred"to"as"CFAN"vehicle"treated"mice),"or"treated"
















Throughout" the" model," changes" in" behavior" and" weight" were" monitored" as" a"
marker"of"animal"well9being.""Weight"changes"of"the"mice"over"the"129week"model"
timeframe"are"depicted" in"Figure"591,"the"black"dotted" line"represents"the"sodium"
bicarbonate" treated"mice" (Normal" controls),"while" the" thick" black" line" represents"
the" CFAN" vehicle9treated" mice," the" purple" line" represents" CFAN" ASO1439treated"
mice" and" the" blue" line" represents" CFAN" ASO1669treated" mice." " There" was" a"
significant"drop"in"weight"seen"at"day"3"and"day"25"in"all"folic"acid9treated"animals,"
following" each" injection" and" coinciding" with" presumed" episodes" of" acute" kidney"
injury.""Although"these"mice"quickly"recovered"their"weight,"they"gained""at"a"slower"
rate"than"the"normal"controls"as"described"in"chapter"3.""The"weight"of"the"normal"
control" mice" peaked" at" day" 42," and" then" plateaued." " By" day" 85" there" was" no"
significant" difference" in" weight" between" the" CFAN" mice" and" the" normal" control"













Weight' changes' of' the' CD1' mice' throughout' the' 12' week' therapeutic' study,'
normalised'to'their'starting'weight.''Sodium'bicarbonate'only'treated'mice'(Normal'
controls)' =' black' dotted' line,' CFAN' vehicleFtreated'mice' =' thick' black' line,' CFAN'
ASO143Ftreated' mice' purple' line,' CFAN' ASO166Ftreated' mice' ' =' blue' line.''
Statistical'Analysis:'ANOVA'*p=<'0.05,'**'p=<0.05'SEM.'


















 FA No treatment
FA  ASO 487166


















































































 FA No treatment
FA  ASO 487166











































The"results"are"shown" in"Figure"592." "The" first" two"columns" in"white"show"normal"
controls" (sodium" bicarbonate" IV)." " The" spotted" column" shows" the" CFAN" vehicle"
treated"mice,"followed"by"two"grey"columns,"which"shows"CFAN"mice"treated"with"
either"of" the"K9Ras" targeting"ASO;"each"point" in"a" column" represents"one"mouse.""
Previous"work"documented"in"chapter"3,"shows"that"CFAN"is"associated"with"a"50%"
up"regulation"of"K9Ras"mRNA"when"compared"with"normal"control"mice.""Treatment"





The" effect" of" ASO143" and" ASO166" on" K9Ras" in" CFAN" mice" was" also" analysed" at"
protein" level" using" western" blot" analysis." " Protein" samples" were" extracted" from"
snap"frozen"kidney"samples"and"first"IP"for"pan"Ras"as"described"in"section"2.15.""The"
IP"samples"were"analysed"using"western"blot"for"K9Ras"protein"changes.""The"CFAN"
ASO143" treated" samples" showed" a" 50%" reduction" when" compared" with" CFAN"
vehicle"treated"samples.""This"matched"that"seen"at"mRNA"level.""The"CFAN"ASO166"




When" targeting" K9Ras"with" ASO," it" is" important" to" confirm" that" there" are" no" off9
target"effects"of"the"ASO"or"compensatory"up"regulation"of"the"other"Ras"isoforms"
in" CFAN" mice." " " The" mRNA" expression" of" H9Ras" and" N9Ras" was" analysed" using"
Taqman"QPCR" as" described" previously" for" K9Ras"mRNA." " As" shown" in" Figure" 593,"
there"is"no"significant"change"in"H9Ras"mRNA"between"all"groups"(graph"I).""There"is"







(Graph' I)' KFRas' mRNA' expression' from' kidneys' samples' of' Normal' mice' (white'
columns' with' circles),' CFAN' mice' vehicle' treated' mice' (spotted' column' with'
squares)' or' CFAN' mice' treated' with' KFRas' targeting' ASO' (Grey' column' with'






























Day$0 Day$85 Placebo ASO$166 ASO$143














































































Day$0 Day$85 Placebo ASO$166 ASO$143


































The"effect"of"K9Ras"ASO"on"fibrosis" is"a"primary"endpoint"of"this"study." "Fibrosis" is"













with"either" vehicle,"ASO143"or"ASO166." " The" collagen"deposition" is" highlighted" in"
red"with"other"tissue"and"cytoplasm"stained"in"yellow.""In"the"CFAN"vehicle"treated"
mice" large" areas" of" collagen" deposition" were" seen," these" consistently" surround"
areas"of"blood"vessels"and"glomeruli"and"often"spanned"the"cortex"to"the"medulla.""
When" compared" with" CFAN" mice" that" received" ASO166," there" appeared" to" be"
smaller"areas"of"collagen"deposition,"however"it"is"difficult"to"discern"a"clear"effect"
of" ASO166" on" collagen." " When" comparing" vehicle" treated" with" CFAN" ASO143"
treated"mice"the"collagen"deposition"appeared"to"be"dramatically"reduced,"there"is"




Figure" 594." " This" trichrome" stain" has" three" colours," each" highlighting" a" different"
tissue"type.""Collagen"and"reticulum"are"sustained"blue,"cell"nuclei"appear"blue9black,"
red"blood"cells"stain"yellow"and"muscle"and"fibrin"stain"red.""As"seen"with"PSR"large"
areas"of" collagen"deposition"was"seen" in"vehicle" treated"CFAN"kidneys," treatment"
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with"ASO166"appeared"to"only"mildly"affect"this"with"long"striated"areas"of"fibrosis"
still" present." " Treatment"with" ASO143" showed" a" clear" reduction" of" collagen"with"
blue"staining"only"being"clearly"present"in"areas"of"blood"vessels."""""
"





shows" a" reduction" of" 40%" (n.s.)" in" fibrosis" while" using" PMT9staining" a" significant"
fibrosis"reduction"of"(50%)"(p<0.05)"with"ASO143"treatment"compared"with"vehicle9
treated" CFAN"mice." "When" comparing" the" effect" of" ASO166"with" vehicle" treated"




variation" between" PSR" and" PMT" staining," hydroxyproline" measurement" was"
undertaken." " The" hydroxyproline" assay" (total" collagen" assay)" by" Quickzyme"
(discussed"in"section"2.9"and"chapter"3)"was"used"to"undertake"this"measurement.""
Snap" frozen" kidney" samples" from" the" experiment" described" in" section" 5.1" were"
analysed.""The"hydroxyproline"results"in"Figure"596"shows"a"similar"pattern"resulting"
in" a" significant" 37%" reduction" in" collagen"with"ASO143" treatment" compared"with"
vehicle9treated"CFAN"mice"(p<0.01)." "ASO166"showed"a"reduction" in"collagen"with"























Normal' mice' =' White' columns' with' circles,' CFAN' mice' treated' with' vehicle' ='
spotted'column'with'squares,'CFAN'mice'treated'with'KFRas'targeting'ASO'='Grey'














































































































































Quantification' of' Collagen' using' the'Quickzyme' Total' Collagen'Assay' from' kidney'
samples'of'CFAN'mice'treated'with'vehicle'or'KFRas'targeting'ASO.'
Normal' mice' =' White' columns' with' circles,' CFAN' mice' treated' with' vehicle' ='
spotted'column'with'squares,'CFAN'mice'treated'with'KFRas'targeting'ASO'='Grey'






































As" discussed" in" chapter" 3" the"myofibroblast" or" ‘scar" producing" cell’" as" it" is" often"
referred"to"has"shown"to"be"induced"in"expression"in"the"interstitial"space"between"
the"tubules." "Western"blot"analysis"was"undertaken"with"kidney"samples" from"the"
mice" in" the" 12"week" therapeutic" study." " As" described" in" chapter" 3" there"was" an"
induction" in" CFAN" vehicle" treated" mice" compared" to" Normal" controls." " Upon"




IHC" images" of" α9SMA" staining" were" qualitatively" accessed" for" changes" in" the"
amount" of" α9SMA" expressing" cells"with" treatment" of" ASO143" and"ASO166." "With"
ASO143" treatment" Figure" 598" (bottom" image)," there"was" a" dramatic" reduction" in"



































































































































4μM$ FFPE$ kidney$ sections$ with$ IHC$ for$ α:SMA$ (brown$ Dab$ Substrate)$ in$ CFAN$
vehicle$ treated$mice$ (TOP),$ CFAN$ ASO166$ treated$mice$ (MIDDLE),$ CFAN$ ASO143$











al."2003)." "Prior" to"starting"this"study,"samples" taken"from"a"previous"study" in" the"
UUO" model" were" analysed" for" changes" in" p8ERK" (Wang," Newbury" et" al." 2012).""
Figure"589"depicts"kidney"protein"samples"as"described"in"Appendix"B"2.7"from"Sham,"
UUO" vehicle" treated" Rats" and" UUO" ASO" K8Ras" treated"Wistar" rats." " In" the" sham"






Unexpectedly" the" CFAN" model" is" yet" to" show" a" clear" relationship" with" pERK"
signalling,"which"was"discussed" in"chapter"3,"but"because" such"a" strong" reduction"
was"seen"in"the"UUO"model"we"were"still"interested"to"investigate"if"the"K8Ras"ASO"





12" week" therapeutic" study" by" Western" blot" as" shown" in" Figure" 5810." " Prior" to"
undertaking" of" this" Western" blot" the" samples" were" normalized" to" total" protein.""
Ponceau" S" staining" was" used" to" confirm" this," however" this" did" highlight" uneven"
loading"in"some"cases.""As"described"in"chapter"3"there"appears"to"be"no"dramatic"
induction"of"pERK" signalling,"however"on"analysis"of" the"mice" that" received"K8Ras"
targeting"ASO"there"appears"to"be"a"reduction"of"pERK"in"the"ASO143"treated"group,"






Another" primary" endpoint" in" this" study" was" the" effect" of" K8Ras" ASO" on" renal"
function." " The" two" measures" examined" were:" serum" creatinine" and" Blood" Urea"




As" described" in" chapter" 3," Induction" of" chronic" folic" acid" nephropathy" led" to" a"
tenfold" increase" in" serum"creatinine"and"a"doubling"of"BUN"by"day"84" in" vehicle8
treated"mice.""Treatment"of"CFAN"animals"with"ASO143"resulted"in"a"75%"reduction"





Graph$ I:$ Western$ blot$ of$ pERK$ (Top$ line)$ and$ Total$ ERK$ (Bottom$ line)$ of$ kidney$
samples$from$UUO$model$of$Renal$fibrosis..$$Columns$1:4$–$Sham,$5:8$–$UUO$and$9:










































































































































































































































































this! chapter! the! results! from! these! chapters! have! been! brought! together! to!




Weight! changes!were!monitored! during! this! study! as! a!marker! of!mouse! health.!!
The!significant!drops!in!weight!in!the!CFAN!model!at!day!3!and!day!25!highlights!the!
acute!phases!of!the!model,!after!this!the!CFAN!mice!gained!weight!at!a!slower!rate!
to! that! of! normal! controls.! ! Thus,! suggesting! that! the! animals’! ill! health! was!
affecting!their!ability!to!gain!weight.!!Between!the!CFAN!groups!the!ASO143!gained!
weight! the! fastest! followed! by! ASO166,! then! vehicle! treated,! suggesting! ASO143!
was! the! most! beneficial! in! protecting! the! mice.! ! However,! weight! gain! is! not! a!
perfect!measure! of! animal! health! as! there! are! a! lot! of! external! factors! than! can!
affect! it.! ! In!this!study! it!was!not!always!possible!to!use!the!same!scales!for!every!
weight! time=point,! as! the!measurement! apparatus! was! shared! between!multiple!
researchers!and!often!got!moved!or!sent!away!for!calibration.!!However!each!time!
point!used!the!same!scales!for!all!groups.!!Weight!can!also!be!used!as!a!marker!of!
animal! well! being! or! stress,! meaning! each! injection! received! by! the! mice! could!
result! in!a!drop! in!weight,! just!because!of!the!stress!of!the!procedure!rather!than!
true! illness.! !This! is! seen! in! the!mice! injected!with! sodium!bicarbonate!at!day!25.!!









two! K=Ras! targeting! ASO143! and! ASO166,! therefore! they! will! be! discussed!























resulting! in!non=significant! reductions!with! treatment.! ! ! This!may!be!because! it! is!
difficult! to! distinguish! between! the! red! colour! and! yellow/pink! background! using!
image! analysis! software,! meaning! the! amount! of! collagen! deposition! has! been!






Treatment!with! ASO143! showed! a! reduction! in! α=SMA! staining! via! both!Western!




caused! by! nephrotoxic! drugs.! ! By! sampling! only! a! small! part! of! the! kidney,! the!
amount! of! fibrosis! in! that! sample!might! not! be! representative! of! the! organ! as! a!
whole.! !This!might!be!particularly!problematic! in!a!measure!such!as!α=SMA!that! is!
also! strongly! expressed! in! blood! vessels.! ! If! this! sampling! method! took! a! large!
amount!of! blood! vessels! that!was!not! sampled! in!other! groups! this! could!heavily!
skew!the!results.!!To!overcome!this!limitation!IHC!for!α=SMA!was!also!undertaken,!
allowing! the!analysis! to!be! focused!on! the! interstitial! expression!of!α=SMA! rather!
than!overall! changes.! ! The! IHC! showed! reduction! in!α=SMA!cells! in! the! interstitial!






reducing! pERK! expression! inside! these! kidneys.! ! A! potential! hypothesis! could! be!
that! the! pERK! signalling! occurs! earlier! in! this! model,! which! is! why! no! clear! up=
regulation!is!seen!by!week!12.!!However!by!reducing!the!activity!of!the!pathway!this!






serum! creatinine! and! 32%! BUN! (p<0.05).! ! These! results! gave! a! borderline!
significance.! ! When! analysed! with! both! ASO166! and! CFAN! vehicle! mice! there! is!
more!than!two!groups,!therefore!it!would!be!correct!to!calculate!significance!using!
















a! different! and! less! efficient! result! to! that! shown! previously! in! chapter! 4! when!
healthy!CD!1!mice!were!dosed!with!ASO.!!
!
There!are!many!possible! reasons! for! the!discrepancy!between! the!effect! in!CFAN!









ASO166! had! no! effect! on! the! other! Ras! isoforms,! other! than! a! slight! raised!
















Ras.! ! Suggesting! that! the!greater! the! reduction! in!K=Ras! (until! a! certain!point,!we!
believe!to!be!basal! levels),! the!greater!the!effect!on!reducing!collagen.! !This!most!




ASO166!also!appeared! to! reduce!α=SMA!expression! in! the!CFAN!kidneys,!but! this!





As! discussed! above! and! in! chapter! 3! pERK! does! not! appear! to! have! such! a!
significant!role!in!this!model!at!the!12!week!time!point,!however!the!K=Ras!ASO!did!








on! renal! function!with! the!mice! showing! a! similar! level! of! creatinine! and!urea! to!
that!seen!in!vehicle!treated!CFAN!mice.!!This!is!most!likely!explained!in!part!by!the!




On!analysis! of! all! the! data! it! has! proved!most! likely! however! that!ASO166! is! less!
efficacious! in! reducing!K=Ras!mRNA! levels! in!CFAN!mice! than!ASO143in! the!CFAN!
model,! and! is! therefore! less! effective! at! reducing! fibrosis! and! protecting! against!
renal!dysfunction.!!Although!not!a!significant!finding,!it!was!observed!that!in!most!






pilot.! ! As! a! result,! at! the! beginning! of! this! study! the! technique! required! for!
cannulating!of! the! tail! vein! of! the!mice! for! the!purposes! of! IV! injections!was! still!
being! optimised.! ! In! addition,! this! technique!was!more! challenging!with! the! folic!
acid! solution,! as! it! caused! the! mice! more! discomfort! than! the! vehicle! solution,!








weeks! to! 16! weeks,! as! renal! fibrosis! is! a! slow! progressing! disease,! To! see! if! the!
positive!outcomes!on! fibrosis!of!K=Ras! inhibition!was!also!seen! in!a! longer!model,!
more!fibrotic!model.!!
!
The! 16!week!model!was! undertaken! in! the! same!manner! as! the! 12!week!model,!
using!CD1!male!mice!of!8!weeks!of!age,!with!the!125mg/kg.! folic!acid! IV! injection!
given! at! day! 0! and! day! 21.! ! However,! after! further! discussions! with! Isis!
pharmaceuticals,!I!also!decided!to!change!the!dosing!protocol!of!the!K=Ras!targeting!
ASO.! ! In! this!experiment! I! started! treatment!at!day!35!with!a!100mg/kg/week! for!
the! first! two!weeks,!which!was! then! reduced! to!50mg/kg/week! for! the! remaining!
weeks.!!As!ASO166!did!not!show!a!beneficial!effect!in!the!12!week!model,!this!was!










induced! animals! at! day! 3! and! day! 24! after! the! folic! acid! injections! describe! in!
Chapter!3.!!
 
The!CFAN! induced!mice! appeared!not! to!be! suffering!when! comparing!mice!with!
healthy! controls.! !However!during! the!period!of! running! this!model! there!was!an!
outbreak!of!pasteurella!pneumotropica!within!our!BSU.!!Pasteurella!pneumotropica,!
is! a! gram=negative! opportunistic! pathogen,! can! be! isolated! from! the! oropharynx,!












Weight$ changes$ of$ the$ normal,$ CFAN$mice$ and$ treatment$ groups,$ normalised$ to$
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expression! of! K=Ras! in! all! groups.! ! There! is! a! 50%! induction! in! K=Ras! mRNA!
compared! with! normal! mice! (>0.05),! the! same! is! seen! with! the! control! oligo!
compared!with!the!normal!animals.!!ASO080!gave!a!40%!reduction!in!K=Ras!mRNA!
when! compared! with! Vehicle! treated! animals,! however! this! was! not! significant.!!
ASO143! gave! a! significant! 70%! reduction! in! K=Ras! mRNA! when! compared! with!
Vehicle! treated!animals! (>0.01).! ! These! results!were!confirmed!with!Western!blot!
analysis,!Figure!5=13!Image!II!shows!the!GAPDH!IP!loading!control!and!the!K=Ras!IP!
Western!Blot.!!There!is!low=level!expression!of!K=Ras!protein!in!healthy!animals!this!
was! increased! in! CFAN! induced! mice.! ! On! treatment! with! ASO! 143,! the! K=Ras!
expression!is!reduced!dramatically,!with!no!expression!being!seen!in!some!samples.!!!!
!
To! confirm! the! specificity! of! this! knockdown! H=Ras! and! N=Ras! mRNA! were! also!
analysed!using!Taqman!QPCR.!!Figure=5=15(graph!I)!shows!N=Ras!mRNA!expression,!
there! was! no! change! between! CFAN! vehicle! mice,! ASO! 143,! and! Normal! mice.!!
However,! there! is! 30%! increase! in!N=Ras!mRNA! in! the! CFAN! Control! Oligo! group!
when!compared!with!Normal!(N.S)!and!a!50%!induction!in!N=Ras!mRNA!in!ASO080!
CFAN!treated!mice!when!compared!with!normal!mice!p>0.001.!!Figure=5=15!(graph!




Shows$ total$ kidney$ K*Ras$mRNA$ expression$ in$ normal$mice$ and$ CFAN$mice$ with$
vehicle,$control$oligo,$ASO080$or$ASO143$treatment.$Normal$mice$=$White$columns$
with$ circles,$ CFAN$mice$ =$ spotted$ column$with$ squares$ (vehicle)$ or$ empty$ circles$

























































Figure)5)15:' 16'Week' CFAN'Model:' Effect' of' K)Ras' ASO' on' H)Ras' and' N)Ras' in'
CFAN'mice'
(Graph$ I)$ Shows$ the$ effect$ of$ K*Ras$ ASO$ on$ N*Ras$mRNA$ expression.$ $ (Graph$ II)$
Shows$the$effect$of$K*Ras$ASO$on$H*Ras$mRNA$expression$
Normal$ mice$ =$ White$ columns$ with$ circles,$ CFAN$ mice$ =$ spotted$ column$ with$































































inner! cortex! outer! medulla! region! there! appeared! to! be! increased! collagen!
deposition!compared! to!healthy!mice,!whether! this!was!higher! than!CFAN!vehicle!
treated!mice! it! was! difficult! to! determine.! ! In! the! ASO143! treated!mice! collagen!
deposition!was!also!reduced,!with!small!areas!of!fibrosis!visible!in!some!mice,!again!




with! vehicle! treatment! showed! a! strong! induction! in! collagen! (green/blue),! the!
green!staining!was!not!always!as!clear!in!images!taken!as!that!seen!on!the!screen.!!
After! treatment!with!control!oligo! similar! collagen! induction!was! seen!although! it!
appeared! to! be! slightly! less! than! vehicle! treated!mice.! ! Treatment!with! ASO080,!





mice! showed! a! 25%! increase! in! collagen! deposition! in! the! cortex! of! the! kidneys,!
when! compared! with! control! oligo! this! induction! was! reduced! by! 20%! in! PSR!
staining.!!On!comparison!of!the!vehicle!treated!CFAN!mice!with!ASO080!there!was!
the! same! 20%! reduction! in! collagen! deposition,! on! comparison! with! the! vehicle!
control! and! ASO143! there! was! a! greater! than! 30%! reduction! of! collagen! in! the!
cortex!of!the!kidneys.!!Quantification!of!MT!also!showed!an!induction!of!collagen!in!
CFAN! mice! compared! with! healthy! mice! (25%).! ! The! Control! oligo! and! ASO080!
showed! similar! results! to! the! PSR! staining! with! a! 20%! reduction! in! collagen!
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deposition!when!compared!with! vehicle! treated!mice.! !ASO143! showed!a!greater!
45%!reduction!of!collagen!with!MT,!higher!than!that!seen!with!PSR!staining!(p<0.05).!
!
Collagen!mRNA!was! also!measured! to! see! if! the! same! pattern! of! expression!was!
seen.!Figure!5=18(graph! I)! shows!a!75%!or!60%! induction!of!Collagen!1a!mRNA! in!
CFAN! vehicle! treated! mice! or! control! oligo! respectively! when! compared! with!
normal! mice.! ! ASO143! showed! no! change! in! mRNA! expression! compared! with!
normal!mice!but!is!reduced!by!75%!or!60%!compared!with!vehicle!or!control!oligo!






total! collagen! assay! by!Quickzyme!was! undertaken.! Figure! 5=18! shows! that! CFAN!
vehicle! treated! mice! showed! a! tripling! in! collagen! concentration! compared! to!
normal!animals! (p>0.001),!with!a!similar! induction!seen! in!the!control!oligo!group!
(p>0.01).! ! When! comparing! the! disease! portion! of! the! collagen,! the! portion! of!
collagen!not!seen!in!the!normal!mice!(above!the!dotted!line).!!It!shows!that!ASO143!





4μM$ Sections$ of$ FFPE$ kidney$ samples,$ the$ top$ row$ are$ representative$ images$ of$
from$CFAN$PBS$treated$mice.$$The$2nd$row$is$CFAN$mice$treated$with$Control$Oligo,$









Shows$ Quantification$ of$ PSR$ (Image$ I)$ and$ Masson$ Trichrome$ (Image$ II)$ from:$$
Normal$ mice$ (White$ columns$ with$ circles),$ CFAN$ mice,$ (spotted$ column$ with$
squares$ (vehicle)$ or$ empty$ circles$ (control$ oligo),$ CFAN$ mice$ treated$ with$ K*Ras$










































































































(I)$ Depicts$ collagen$ 1a$mRNA$ expression$ in$ Normal$ and$ CFAN$mice$ treated$ with$
Vehicle,$Control$Oligo,$ASO080$and$ASO$143..$$(II)$Collagen$ug/ml$by$hydroxyproline$
assay$ in$Normal$ and$CFAN$mice$ treated$with$Vehicle,$ Control$Oligo,$ ASO080$ and$
ASO$143.$(**$=p<0.01;$***$=$p<0.001)$$Normal$mice$=$White$columns$with$circles)$
CFAN$mice$=$spotted$column$with$squares$(vehicle)$or$empty$circles$(control$oligo),$









There! is! a! slight! induction!of!α=SMA! in!CFAN!mice.! !With! treatment!with!ASO143!






vehicle! treated.! ! In!CFAN!mice! that!have! received! control! oligo! there!was!also!α=
SMA! expression! in! the! interstitium,! this!was! similar! but! slightly! reduced! in! CFAN!
mice!that!had!received!ASO080.!!In!CFAN!mice!that!had!received!ASO143!there!was!




To!see! if! the!reduction! in!ASO143!was!associated!with!an!anti=proliferative!effect,!
Ki67!was!examined!in!these!samples!rather!pERK.! ! In!normal!mice!very!few!nuclei!
stained!positive!for!Ki67!(brown),!however!on!induction!of!CFAN!in!the!mice!there!































IHC$ images$ of$ Ki67$ staining$ (brown)$ in$ 4μM$ FFPE$ kidney$ sections$ from$ paraffin$











the! 16!week!model.! ! BUN!was! analysed!with! the!Max!Discovery! Enzymatic! assay!
discussed! in! Chapter! 3.! ! Figure! 5=22! shows! the! quantification! of! urea! in! serum!
samples! from! Normal! and! CFAN!mice! treated! with! either:! vehicle,! control! oligo,!
ASO080!and!ASO143.!!As!described!chapter!3!the!CFAN!vehicle!treated!mice!show!
almost!doubling!of!urea!compared! to!healthy!mice! (p<0.001).! ! .! The!control!oligo!
surprisingly!did!not!show!the!same!result,!giving!a!20%!reduction!in!urea!compared!
with!CFAN!vehicle!treated!animals!(n.s.).!!On!analysis!of!ASO080!it!shows!the!same!









Normal$ mice$ =$ White$ columns$ with$ circles,$ CFAN$ mice$ =$ spotted$ column$ with$




















































deposition!with! CFAN! vehicle! treated!mice),! although! a! significant! reduction!was!
only!seen!with!MT!(45%).!!.!!One!difference!between!the!measurements!is!that!the!
PSR! and! PMT! staining! focuses! on! the! cortex! of! the! kidney! whereas! the!
hydroxproline! assay! also! includes! the! medulla.! ! In! this! dataset! all! three! assays!
showed! the! same! pattern! of! change,! of! collagen! reduction! when! treated! with!
 203 





blot! analyses! and! IHC.! The! IHC! clearly! shows! the! differences! between! α=SMA!






was! measured! in! normal! and! CFAN! kidney! sections.! ! CFAN! vehicle! treated! mice!
showed! a! large! increase! in! proliferating! cells! particularly! in! the! interstitial! space;!






in!urea!observed.! ! This!was!not! as! large! as! the!32%! reduction! seen!with!ASO143!
(P<0.05)! in! the!12!week!model.! ! This! finding!did!not!match! the! reduction! seen! in!
fibrosis,!which!was! surprising! as! fibrosis! is!meant! to! be! the! strongest! histological!
correlate! to! renal! function.! ! Unfortunately! creatinine! was! not! analysed! in! these!
samples!as!a!comparative!marker.!!In!order!to!fully!understand!these!results,!both!
creatinine! and! cystatine! C! needs! to! be! measured! in! both! the! 12! and! 16! week!
models.!
!
One! cannot! rule! out! that! the! abnormality! in! this! result! might! be! due! to! the!
outbreak! of! Pasteurella! pneumotropica! in! the!BSU! causing! additional! effects! that!













ASO080! had! variable! and! in! general,! non=significant! impact! on! the! parameters!
measured.! ! This! could! be! due! to! a! number! of! reasons! including! low!














able! to! calculate! them.! ! ! To! try! any! understand! whether! this! study! was!













































































protein.! ! It!has!been!shown!that!when!Notch!1!binds!to! its! ligand,!Jag!1,! it!causes!
the!activation!of!the!metalloproteinase!ADAM17.!!ADAM17!cleaves!the!extracellular!
portion!of!Notch!1,!which! is! then!released!by!endocytosis!by!the!Jag!1!expressing!
cell!and!activates!a!signalling!cascade! in!the!signal=receiving!cell.! !The! intracellular!
portion!of!Notch!1!(on!the!Notch!expressing!cell)!is!subsequently!cleaved!by!the!Υ=
secretase! complex,! releasing! the! active! portion! of! the! Notch! protein,! the! Notch!




The! complex! relationship! between! Ras! and! Notch! first! occurs! in! development!
where! both! pathways! are! highly! active! in! controlling! many! different! biological!
processes.! ! ! Collaboration! between! the! Ras! and! Notch! pathways! has! been!
previously!described! in! the!development!of! the!Caenorhabditis! elegans! vulva!and!
the! Drosophila! eye.! Sundaram! describes! how! Ras! and! Notch! signalling! varies!
according! to! the! cell! type! in! which! they! are! expressed.! ! In! the! P6.p! cell! of! the!
C.elegans!vulva!and! in!the!R!cells!of! the!drosophila!eye,!activation!of!Ras! leads!to!
upregulation! of! DSL! ligands! e.g.! Jag! 1.! ! The! increase! in! these! ligands! in=turn!
activates! Notch! in! the! surrounding! cells.! ! However,! Notch! has! been! shown! to!






To! test! the!hypothesis! that!K=Ras! is! reducing! fibrosis!by!affecting! the!Notch/Jag!1!
pathway!we!used!the!MPTEC!model!described!in!Section!6.2.!!This!model!allows!us!
























The! second! model! uses! epithelial! cells! stimulated! with! TGFβ1,! which! undergo! a!
morphological! change! into! a! fibroblast! ‘like’! phenotype! in# vitro! thus! making! it! a!
model!of!epithelial!to!mesenchymal!transition!(EMT).!!Although,!on!balance,!EMT!is!
unlikely! to! contribute! significantly! to! the! development! of! renal! fibrosis! in# vivo,!





Mouse! Proximal! Tubule! Epithelial! Cells! (MPTECs)! were! characterised! using! the!
markers! AQP1,! a! proximal! tubule! marker,! and! E=cadherin,! an! epithelial! marker.!!
Cells!were!seeded!into!35mmm!dishes!and!grown!to!around!80%!confluent!in!their!
standard! growing! medium.! ! They! were! then! washed! with! PBS,! fixed! using!
paraformaldehyde!and!permabilised!with!triton!X=100.!!The!cells!were!then!stained!
with! the! primary! antibodies,! anti=AQP1;! anti=E! cadherin! and! their! respective!
secondary!antibodies,!anti=rabbit!IgG!linked!to!alexaflur!488;!anti=mouse!IgG!linked!
to! alexaflur! 555.! ! The! cells! were! finally! counterstained! with! Dapi! and! visualised!
under!a!fluorescent!microscope,!Nikon!eclipse!TE2000=S.!Figure!6=2!shows!that!the!




Concentrations!of! 1,! 2.5,! 5,! 10ng/ml!of! TGFβ1!were! tested! for! collagen! induction!
along!with! the! loss! of! the! epithelial!marker,! E! cadherin.! ! Cells! were! seeded! into!




and! protein! was! extracted! and! collagen! 1a! mRNA! and! E! cadherin! protein! were!
measured.! ! Graph! I! shows! that! collagen! induction! occurs! in! a! dose=dependent!
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fashion!with! a! doubling! effect! seen! at! 1ng/ml! and! 2.5ng/ml! compared! to! 0ng/ml!
and! 1ng/ml! respectively.! ! Further! increases! were! seen! at! 5ng/ml! and! 10ng/ml!
TGFβ1!treatment.!!
!
Western! blot! analysis! showed! loss! of! E=cadherin! at! 1ng/ml! of! TGFβ1! and! doses!
greater!than.!5ng/ml!of!TGFβ1!was!chosen!for!the!use!in!model!2!for!the!induction!





This! model! was! also! conducted! at! the! two! time! points! of! 24hr! and! 120hr,! to!
evaluate! the! effects! of! short! and! long=term! cytokine! stimulus! on! the! cells.! ! Cells!
underwent!reverse!transfection!with!either:!vehicle,!200nmol!K=Ras!ASO!(ASO!143)!
or!200nmol!control!oligo,!they!were!then!plated!in!a!dish!and!left!overnight!to!grow,!







The( left( hand( column( contains( images( of( MPTECs( stained( with( AQP1( (green),( E?















Graph( I( Shows( fold( change( of( collagen( mRNA( in( MPTECS( treated( with( different(
concentrations(of(TGFβ1.( (Black(column((left)(=(untreated,(Dark(grey(to(white((left(
to(right)(=(1ng/ml,(2.5ng/ml,(5ng/ml(and(10ng/ml.( ( Image(II(Western(blot(showing(
change( in(E?cadherin( (top( line)( in(MPTECs(with(different(concentrations(of(TGFβ1.((
Bottom(line(=(HSP70,(housekeeping(gene.(
  



























































































































































1.5! fold! at! 120hr,! in! mouse! proximal! tubular! cells! in! culture! (MPTECs)! this! is!
attenuated!by!68%!upon!treatment!with!ASO143!at!24!hr!and!67%!at!120hr,!back!to!
basal!levels.!!N=Ras!(Graph!II)!and!H=Ras!(Graph!III)!mRNA!levels!were!also!measured!
at! 24hr! and! showed! an! induction! with! TGFβ1! treatment! of! 90%! and! 100%!







fold! respectively! in! the! control! oligo/TGFβ1! treatment! groups! compared! with!
untreated!cells.! !At!24hr,! treatment!with!K=Ras=targeting!ASO! (ASO143)! showed!a!
reduction!in!collagen!1a!expression!of!!25%;!(non=significant!)!at!120hr!there!was!a!




(Graph( I)( K?Ras( expression( (Graph( II)( N?Ras( expression( and( (Graph( III)( H?Ras(
Expression(in(untreated(MPTECs((white)(or(MPTECs(treated(with(5ng/ml(TGFβ1(and(































































































































































































































































in!MPTECs!after!TGFβ1!and!K=Ras!ASO!treatment.! !There! is!a!5.2!fold!rise! in!Jag!1!
mRNA! expression! with! TGFβ1! treatment! (black! column)! when! compared! to!
untreated! cells! (white! column)! at! 24hr;! this! did! not! change! with! K=Ras! ASO143!




Ras! ASO143! treatment.! ! Protein! changes! of! Jag! 1!were! also! analysed,! Figure! 6=8!
shows! the! induction! of! Jag! 1! protein! with! 120hr! of! TGFβ1! treatment! and! the!
attenuation!of!this!with!K=Ras!ASO143!treatment.!!!
!
There!was! no! significant! change!with!Notch! 1!mRNA!with! TGFβ1! stimulus,!which!
matches!previously!published!data.!!Due!to!the!increase!in!Jag!1!protein!we!would!
expect! Notch! 1! to! become! activated.! To! try! and! measure! Notch! 1! activation! an!
active! notch! antibody! from! Abcam! plc! was! tested! by! Western! blot! analysis.!!
However!the!active!notch!antibody!was!ineffective!at!binding!to!the!active!portion!
of! the! protein! and! no! results! were! obtained.! ! After! discussion! with! Abcam! they!





therapeutic! study.! mRNA! was! extracted! and! analysed! from! these! samples! using!
Taqman!primer!probes!for!Jag!1!expression!(as!described!in!methods).!!Figure!6=10!
shows! induction! of! Jag! 1! in! CFAN! animals! compared! with! healthy!mice.! ASO143!
treatment!was!associated!with!a!non=significant!25%!attenuation.!!On!examination!
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association,! it! is! important! replace!K=Ras!back! into! the!experiment.! !To!replace!K=
Ras!back!into!the!experiment!a!K=Ras!expressing!plasmid!was!used.!!The!human!K=
Ras!gene!was!inserted!into!the!eGFP=C3!plasmid!linked!to!an!eGFP!gene.!!This!acts!
as! a! reporter! for! location! of! the! human! K=Ras! protein! in! the! transfected! cells! by!
fluorescing!green.!!!
!




line! with! the! with! the! empty! plasmid! transfection! rate.! ! In! the! K=Ras! plasmid!








To! investigate!whether!the!changes! in! Jag!1!expression!with!K=Ras!ASO!treatment!
are!causative!or!simply!an!association,!K=Ras!and!control!plasmids!were!transfected!
alongside!K=Ras!ASO!or!Control!oligo!using!reverse!transfection.!In!the!optimisation!
experiment! transfection! of! the! K=Ra! plasmid!was! effective,! however! this!was! not!
reproduced!in!the!final!experiment.!!The!data!show!in!Figure!6=13and!in!Figure!6=14!
clearly!shows!that!the!K=Ras!plasmid!transfection!had!not!been!effective! in!all! the!





Group! Antisense!Treatment! Plasmid!Treatment! TGFβ1!Treatment!
1! Control!! Control!! No!TGFβ1!
2! Control! K=Ras! No!TGFβ1!
3! Control! Control! TGFβ1!5ng/ul!
4! K=Ras!! Control! TGFβ1!5ng/ul!
5! Control! K=Ras!! TGFβ1!5ng/ul!
6! K=Ras! K=Ras! TGFβ1!5ng/ul!
Table!6)1!Experimental!design!for!K)Ras!Replacement!
!
The! results! from! this! protocol! are! shown! in! replicate! 1! and! in! replicate! 2.! ! In!
replicate! 1! collagen! 1a! induction! was! seen! in! both! control! plasmid! and! K=Ras!
plasmid!when!treated!in!unison!with!the!control!oligo!(ASO!con)!and!TGFβ1.!!The!K=
Ras!plasmid! treated!groups! showed!a! lower!collagen!1a! induction!compared!with!
control! plasmid! treated! group.! ! Jag! 1! expression! in! cells! treated! with! TGFβ1,!
ASO143!and!either!plasmid!showed!an!induction!compared!with!cell!that!received!
no!TGFβ1.! !On! comparison!between! the! samples! from! the! same!group! that!once!
treated!with!AS143!the! induction!was!of!Jag!1!was!attenuated.! !All!TGFβ1!treated!
groups! showed! an! induction! of! Jag! 1! expression! compared! with! untreated! cells.!!
Human=K=Ras! analysis! suggests! that! the! primer! was! not! specific! as! the! human!
specifc! K=Ras! primers! amplified!mRNA! in! groups! that! had! not! received! the! K=Ras!




In! replicate!2! the! same! induction!of! collagen!1a!was! seen!with!TGFβ1! treatment,!
































































































































































vehicle& or& K?Ras& plasmid.& & The& samples&were& immunoprecipitated&with& a& pan?Ras&
































































































































































































































































































































































































































































 ((  
0246810
Jag1 


































































































































































In#epithelial# cells# stimulated#with#TGFβ1# there#was#a#5.2/4# fold# induction#of# Jag#1#
mRNA#and#protein#at#the#24hr/120hr#time#point.# #This#matches#the# literature#that#
TGFβ1#is#a#known#to#stimulate#the#expression#of#Jag#1#in#the#kidney#(Sharma,#Sirin#et#
al.# 2011).# # TGFβ1# also# stimulated# a# 19# and# 28# fold# induction# in# collagen# 1a#
expression# respectively,# along#with# a# 100%# and# 150%# increase# in# KPRas#mRNA# at#








not# due# to# direct# interactions# and# requires# signalling# via# other# molecules# which#
requires#more# time#before# the#signal# is# transmitted.# # In#hindsight,# the# later#120hr#
timePpoint# was# the#most# appropriate# time# for# this# type# of# intervention,# allowing#
sufficient#time#for#the#knockdown#to#be#achieved#at#the#protein#level.###
 
A# similar# pattern# of# Jag# 1# expression# was# seen# in# CFAN# animals,# which# was# also#
reduced# with# treatment# with# KPRas# ASO.# # Although# this# result# did# not# reach#
significance,# this# could# be# because# whole# kidney# RNA# was# analysed,# rather# than#
RNA# extracted# from# individual# cell# types.# # This#was# also# demonstrated# at# protein#









ASO143# groups,# particularly# in# replicate# 2.# # There# are#many# possible# reasons# for#
this:# it’s# conceivable# that# the#plasmid# and# the#ASO#are# inhibiting# each#during# the#
transfection# process,# by# binding# to# each# other,# it# is# also# possible# that# the# dual#
transfection# method# of# the# plasmid# and# ASO# results# in# cell# death# meaning# the#
transfected#cells#are#never#analysed.##In#an#ideal#scenario,#the#ASO#would#have#been#














affects# Jag# 1# expression# in# epithelial# cells.# # However,# when# treated# with# TGFβ1,#
these#cells#undergo#epithelial#to#mesenchymal#transition#and#it#is#possible#that#the#
increased#expression#of#Jag#1#is#a#marker#of#a#more#mesenchymal#phenotype.##It#is#
also# possible# that# the# culture# becomes# a# mixture# of# both# epithelial# and#
mesenchymal#cells#and#that#this#is#important#for#the#change#in#expression#of#Jag#1.##







The#work#presented# in# this# thesis# demonstrates# the# creation#of# a# novel#model# of#
CKD,#the#chronic#folic#acid#nephropathy#model,#which#showed#induction#of#collagen#
deposition#at#both#12#and#16#weeks#post#the#initial#folic#acid#injection.##This#increase#
in# collagen# is#associated#with#a#doubling#of#KPRas#mRNA,#with# little# change# in# the#





collagen# measurements.# # This# was# associated# with# a# reduction# in# αPSMA,#
symbolizing# a# reduction# in#myofibroblasts# ‘the# fibrosis# producing# cells’.# # The# ASO#
also#appeared#to#have#antiPproliferative#effects#by#reducing#the#expression#of#both#
pERK# and# Ki67.# # In# the# 12# week# model# this# was# associated# with# a# reduction# in#
creatinine# and#Urea# demonstrating# a# degree# of# renal# protection.# # KPRas# targeting#
ASO166# showed# a# similar# trend# with# all# results;# the# effect# was# just# milder# most#
likely# due# to# the# reduction# in# KPRas# not# being# significant#with# this# ASO.# # ASO080#
showed#a#complex#range#of#results#that#will#be#discussed#below.#
#
120hr# TGFβ1# stimulation# of#MPTECs# resulted# in# the# repression# of# RASAL1,# which#
was# not# seen# in# Vero# cells.# # TGFβ1# stimulation# leads# to# an# induction# in# KPRas,#
Collagen#1a#and# Jag#1#mRNA.# #After# treatment#with#ASO143,#which#reduces#KPRas#










There# is# an# emerging# body# of# evidence# that# Ras# is# a# key# regulator# of# fibrosis,#





The# CFAN# model# is# AKI# to# CKD# injury# model;# in# recent# years# there# have# been#
increased# interest# in# the# role# of# AKI,# as# a# risk# factor# for# CKD.# # Although# AKI# is#
associated#with#a#high#mortality,#it#has#been#believed#for#many#years#this#process#is#
reversible# with# little# longPterm# complications# to# the# kidney.# # It# has# now# been#
recognized# that# incomplete# renal# repair# following# acute# kidney# injury# can# lead# to#
CKD#in#around#20%#of#patients#(Chawla#2011).##This#phenomenon#of#progressing#to#
CKD#is#seen#in#only#a#percentage#of#patients#and#was#associated#with#epithelial#cell#
cycle# G2/M# arrest.# # Yang# et# al# demonstrated# that# after# an# acute# kidney# injury,#
G2/MPcell#arrest#occurs#in#the#proximal#tubular#cells,#causing#the#activation#of#the#CP
Jun#NH2Pterminal# kinase# (JNK)# signalling# pathway,#which# is# known# to# upPregulate#
proPfibrotic# cytokines,# therefore# stimulating# the# fibrotic# pathway.# # If# the# JNK#
stimulus# is# inhibited,# or# the# G2/M# arrest# bypassed# the# kidney#was# able# to# repair#
itself# and# did# not# progress# to# CKD# (Yang,# Besschetnova# et# al.# 2010).# # In# a# review#
article#by#Wynn#et#al#he# linked#this#work#with# the# findings# from#Bechtel#et#al#and#
suggested#that#after#the#cell#cycle#effect#if#methylation#occurs#in#RASAL1,#resulting#
in#constant#Ras#Activation,#this#could#be#the#switch#between#AKI#to#CKD#progression.##
However# if# methylation# does# not# occur# then# the# cell# rights# itself# and# the# kidney#











any# other# rodent# models# of# CKD.# # This# is# most# likely# explained# by# the# lack# of#
potential#therapeutics#to#specifically#target#KPRas.##Meaning#Ras#has#previously#been#
targeted# in# an# unspecific# manner# in# many# multiple# rodent# models# of# CKD,# most#
commonly#by#the#cancer#drug#FTS.##As#discussed#in#the#introduction#FTS#targets#Ras#







fibrotic# diseases.# # In# a# recent# trial# in# pulmonary# fibrosis,# Nintedanib,# a# multiple#
tyrosine#kinase# inhibitor#was# tested# in#1066#patients# in#3:2# ratio#of#Nintedanib# to#
placebo.# # In# the# patients# receiving# the# tyrosine# kinase# inhibitor# compared# with#
placebo# treated# there#was# amelioration# in# lungPfunction# decline# and# fewer# acute#
















of# rodent#models# available# to# access# disease# specific#mechanisms,# with# different#
animal#models#one# is#able# to#mirror#various#elements#of#human#CKD.# #To#validate#
various#therapeutic#approaches#a#variety#of#CKD#models#must#be#used.####
 
The# traditional# protocol# of# folic# acid# nephropathy,# of# one# high# dose# of# folic# acid#









In# our# adapted# model# of# folic# acid# nephropathy:# when# two# doses# of# folic# acid#
(125mg/kg)#were#administered#at#day#0#and#day#21.##The#model#spanned#between#
12# and# 16# weeks# and# we# have# able# to# overcome# some# of# these# limitations..##
Although#our#model#of#12P16#weeks#is#not#a#fast#progressing#model#it#is#shorter#than#
that#of# the#original# protocol,# by# lowering#each#dose#of# folic# acid#no#animal#death#










moderate# increase# in# collagen# and# urea,# questioning# whether# this# adaption# was#
 233 
required# or# not.# # In# hindsight# an# increase# in# N# numbers# might# have# been# more#
useful.##
*
Two# other# wellPused# models# of# renal# fibrosis# were# also# considered:# the# 5/6#
nephrectomy# or# the# aristolochic# Acid.# # The# 5/6# nephrectomy# model# has# the#










many# injections#when# paired#with# ASO# treatment,# for# our# current# project# license#
and#was#therefore#discounted.##Since#starting#this#study#newer#protocols#have#been#










Antisense# oligonucleotides#were# used# to# knockdown# KPRas# in# these# studies.# # The#






Although# ASO# have# been# previously# used# in# our# laboratory# to# target# KPRas# these#
were# specific# for# rat# KPRas.# # Therefore# the#ASO# in# this# study#were# new#and#were#




making# them# a# good# choice# as# antiPfibrotic# medication.# # They# have# increased#
specificity,#therefore#allowing#them#to#target#KPRas#over#the#other# isoforms.# #They#
are#also#very#small,#and#can#enter#cells#following#systemic#administration#in#vivo#and#
so# do# not# require# viral# vectors# as# one# would# with# when# using# RNA# interference#
(RNAi).# #RNAi# is#another#method#of#gene#silencing# that#uses#small# interfering#RNA#











CD1# mice,# were# later# used# in# CFAN# mice.# # # Interestingly# the# ASO# had# different#





Another# problem# raised# with# the# use# of# ASO# is# the# appropriate# control.##






it# showed# no# effect,# however#we# never# screened# these# oligos# for# their# effect# on#
other# members# of# the# signalling# cascade.# # It# is# very# difficult# to# screen# an# oligo#




required.# # No# one# ever# designs# a# chemically,# similar# small# molecular# without# its#








animals#would# be# given# control# oligo# or# vehicle# and# the# samples# processed# on# a#
microarray# to# see#what# effect# this# oligo#was# having# on# other# targets.# # The# same#
would#need#to#be#done#for#the#KPRas#targeting#ASO.##Another#precaution#would#be#
to#run#multiple#control#oligos#in#one#study#or#even#a#mixture#of#oligos#to#nullify#any#








35.# # This# was# chosen# as# it# was# after# the# acute# phase# of# the# disease.# # This# was#
decided#for#two#reasons,#we#were#firstly#trying#to#analyse#the#effect#of#inhibiting#KP
Ras# on# fibrosis# rather# than# on# AKI# and# therefore# felt# that# an# earlier# treatment#
protocol#would#interfere#with#this.##Another#reason#for#starting#treatment#at#day#35#
was#concerns#that#inhibiting#Ras#around#AKI#could#affect#the#kidneys#ability#to#heal.##





benefit# of# KPRas# inhibition# can# only# be# extrapolated# to# early# stage# treatment#
scenarios.# # Fortunately# AKI# to# CKD# patients# are# a# group# of# patients# where# early#


















fibrosis# in#the#kidney.# # In#future#studies#frozen#samples#preserved#for#cryosections#
would# also# be# stored# for# CD68# and# F4/80# staining# in# these# samples.# CD68#would#
also#be#analysed#with#taqman#primer#probes#to#look#for#changes#in#its#expression.#
7.6 Looking*at*K3Ras*ASO*as*a*therapy*
After# all# the# additional# experiments# highlighted# above# are# completed# These#





prior# to# future# therapeutic# studies.# As# this# data# demonstrates# the# efficacy# of# the#
knockdown# appears# to# be# different# between# healthy# and# diseased# mice.# # # Also,#
when#comparing#ASO143# in# the#12#and#16#week# there#was# little#benefit#on#KPRas#
reduction#with#the#higher#dose#treatment,#however#this#higher#dose#only#heightens#





To# be# able# to# treat# humans# in# clinical# trials# it# would# be# beneficial# to# be# able# to#
monitor# KPRas# nonPinvasively.# # One# idea# of# this# is# to# take# urine# samples# from#











commonly#used# is# creatinine,#however# for# creatinine# to#be# raised# the#patient#has#
already# lost#more# than#50%#of# their# kidney# function.# # For# an# antiPfibrotic# therapy#
this#would#be#too#late#to#start#treatment.##In#addition#creatinine#measurements#do#
not#distinguish#between#AKI#and# fibrotic#CKD#Our#own#groups# is# looking# in# to# the#





the# RasGap# RASAL1.# # In# our# hands# this# effect# was# only# seen# in# proximal# tubules#
suggesting#a#cell#dependent#response#in#vitro#(Appendix#A#10).##In#vivo#in#CFAN#mice#
no#clear#regulation#of#RASAL1#was#seen#when#comparing#healthy#and#disease#mice#
(Appendix# A# 10).# # Which# might# strengthen# the# argument# that# this# is# a# cell#
dependent,# as# the#RNA#analysis#was#done#on#whole# tissue# lysates#possible#hiding#
key# changes# in# regulation.# # Bechtel# et# al# showed# that# RASAL1# was# silenced# by#
methylation;#unfortunately#due#to#technical# issues#we#were#unable#to#confirm#this#
in# our# in# vitro# samples.# # Ras# activation# would# also# need# to# be# analysed# in# these#
samples# to# confirm# that# RASAL1# is# having# this# effect# in# these# cells.# # Bechtel#et# al#
linked# the# methylation# of# RASAL1# with# Dnmt1,# a# DNA# methyltransferase.# # I#










transcription# factor,# stimulating# the# expression# of# markers# such# as# αPSMA.##
Regardless#of#MeCP2#role#as#a#repressor#or#activator#it#expression#has#been#shown#
to# be# up# regulated# in# multiple# models# of# fibrosis,# irrespective# of# its# role# as# a#





was# shown# to# be# an# MeCP2# dependent# pathway,# when# MeCP2# was# suppressed#
using#Zebularine,#TGFβ1#did#not#stimulate#αPSMA#induction#(Zhou,#Lu#et#al.#2011).#
#















between# Jag# 1# and# Ras# in# renal# cells# was# previously# unknown.# # The# data#








for# such# a# transfection# heavy# set# of# experiments# with# transfection# proving#






however# it# does# not# allow# us# to# conclude# that# this# is# purely# a# KPRas# dependent#
effect,#as#we#did#not#remove#the#other#Ras#isoforms#from#the#equation.##To#do#this#
further#experiments#would#be#required,#most#likely#using#cells#from#knockout#mice#
of#NPRas#and#HPRas.# #The#limitation#of#such#an#experiment# is#that# in#knockouts#for#













this# out# as# general# Ras# pathway# in# renal# fibrosis,# rather# than# a# KPRas# specific#












































































































































fibrosis$both$ in#vitro$and$ in#vivo.$ $Data$is$also$presented$suggesting$a$role$of$K2Ras$
inhibition$ in$ protection$ of$ Kidney$ function,$ thus$ confirming$ K2Ras$ as$ a$ potential$
therapeutic$target$in$the$treatment$of$renal$fibrosis.$$This$thesis$concludes$with$an$
hypothesis$ pathway$ of$ the$ roles$ of$ K2Ras$ in$ the$ progression$ renal$ fibrosis.$ $ This$
pathway$highlights$three$main$areas$of$further$study:$a)$The$role$of$MeCP2$in$this$
process,$b)$The$replacement$of$K2Ras$to$show,$K2Ras$is$causative$in$the$changes$of$
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Following$ un2blinding$ of$ the$ samples$ it$ became$ clear$ that$ the$ same$ two$ animals$
from$ the$ CFAN$ induced$ group$ had$ failed$ to$ gain$ any$ fibrotic$ phenotype$ in$ all$














Normal* mice* =* White* columns* with* circles,* CFAN* mice* treated* with* vehicle* =*
spotted*column*with*squares,*CFAN*mice*treated*with*KMRas*targeting*ASO*=*Grey*













































































































































Quantification* of* Collagen* using* the*Quickzyme* Total* Collagen*Assay* from* kidney*
samples*of*CFAN*mice*treated*with*vehicle*or*KMRas*targeting*ASO.*
Normal* mice* =* White* columns* with* circles,* CFAN* mice* treated* with* vehicle* =*
spotted*column*with*squares,*CFAN*mice*treated*with*KMRas*targeting*ASO*=*Grey*

































































































Ras$ GTPases$ are$ involved$ in$ many$ different$ transduction$ pathways$ and$ undergo$
many$different$mechanisms$of$ regulation$as$described$ in$ the$ introduction.$ $ It$was$
recently$highlighted$by$Bechtel$et#al$that$epigenetic$regulation$is$one$way$in$which$
Ras$GTPases$can$be$controlled$(Bechtel,$McGoohan$et$al.$2010).$$They$showed$that$
the$ gene$ for$ RASAL1$ in$ kidneys$ underwent$ hypermethylation$ following$ fibrotic$
stimuli$ resulting$ in$a$marked$reduction$ in$RASAL1$expression.$ $As$explained$ in$the$
introduction,$RASAL1$is$a$Ras$GTPase$activating$protein$(Ras$GAP).$$Its$function$is$to$
augment$the$intrinsic$ability$of$Ras$to$hydrolyse$GTP$to$GDP,$thus$converting$active$
Ras$ back$ into$ its$ inactive$ state.$ $ Therefore,$ when$ the$ RASAL1$ gene$ is$
hypermethylated$ (and$ hence$ not$ expressed)$ Ras$ remains$ in$ an$ active$ state$ for$
longer,$once$activated,$which$ leads$ to$progressive$ fibrosis.$ $The$ role$of$RASAL1$ in$
fibrosis$has$been$shown$in$multiple$organs,$Tao$et#al$showed$that$in$hepatic$fibrosis$
RASAL1$ expression$was$ also$ down$ regulated$ and$ this$was$ associated$with$ an$ up2





switch$ factor$ in$ the$progression$of$acute$kidney$ injury$ (AKI)$ to$CKD$ (Wynn$2010).$$
The$ epigenetic$ changes$ of$ Ras$ GAPs$ in$ disease$ have$ been$ further$ looked$ at$ in$
cancer.$ $ In$ a$ publication$ by$ Calvisi$ et# al$ they$ highlight$ the$ importance$ of$ the$
hypermethylation/silencing$ of$ Ras$ GAPs$ in$ liver$ carcinoma.$ $ They$ examined$ Ras$
GAPs:$NF1,$DA2iP$as$well$as$RASAL1$and$showed$that,$ in$patients$with$no$mutant$








widely$ used$ in$ our$ laboratory$ and$ were$ characterised$ for$ use$ in$ other$ studies$





medium$ supplement$ with$ 10%$ FCS$ at$ 1$ in$ 10$ density,$ (taking$ into$ account$ the$
surface$ area$ of$ the$ dish)$ and$ allowed$ to$ grow$ for$ 24$ hours.$ $ The$ medium$ was$
removed$and$cells$were$washed$with$PBS.$Fresh$medium$supplemented$with$0.5%$
FCS$ was$ added$ and$ left$ overnight.$ $ The$ cells$ were$ subsequently$ treated$ with$
different$ concentrations$ of$ TGFβ1$ ranging$ from$ 0ng/ml$ to$ 50ng/ml$ for$ 24hr$ and$
RNA$extracted$using$method$described$in$section$2.11.1.$$
 
The$ RNA$ was$ subsequently$ analysed$ using$ taqman$ QPCR.$ $ Graph$ I$ shows$ QPCR$
mRNA$ fold2change$ of$ collagen$ normalized$ to$ GAPDH.$ $ The$ highest$ induction$ of$
collagen$was$seen$at$5ng/ml$of$TGFβ1$after$24hr$at$a$3$ 2fold$ induction$compared$













concentrations$ of$ TGFβ1$ proliferated$ more$ slowly$ than$ untreated$ cells,$ and$
 265 















Cells$ were$ seeded$ into$ 35mm$ dishes$ and$ left$ to$ grow$ for$ 24hr,$ as$ described$ in$
methods.$$The$medium$was$then$changed$from$DMEM$supplemented$with$10%$FCS$
to$medium$ supplemented$with$ 0.5%$ FCS.$ $ They$were$ left$ overnight$ to$ allow$ the$
fibroblasts$ to$ become$ quiescent$ prior$ to$ the$ treatment$ with$ TGFβ1.$ $ They$ were$










treatment.* * Graph* II* Shows* %* toxicity* measured* using* LDH* release* as* a* marker.*
Black* to* white* column* is* 1ng/ml* to* 50ng/ml* TGFβ1* concentrations.* * The* image*












































































































































































































































































































































































Collagen! IV! (QPCR)!mRNA!fold5change! in!quiescent! fibroblasts! (Vero!cells)! treated!

















































































RNA$ samples$ extracted$ from$ model$ 1$ were$ analysed$ using$ taqman$ QPCR$ for$
changes$in$RASAL1,$NF1,$DA2IP$and$PITX1.$There$was$no$change$in$DA2IP$or$NF1$at$
either$time$point.$ $There$was$no$change$on$RASAL1$mRNA$expression$at$the$24hr$





RNA$ samples$ from$ the$ optimization$ of$ model$ 2$ were$ analysed$ to$ see$ if$ similar$






treated$ samples$ in$ this$model$ differ$ from$ the$ previous$ samples$ analysed$ as$ they$






$Graph$ II$ shows$ no$ change$ at$ 24hr$ time$ point,$ in$ all$ treatment$ groups$ but$ a$
significant$80%$reduction$was$seen$at$ the$120hr$ time$point$ in$both$TGFB1$groups$



















































































































































































































































































































































































The$ paper$ by$ Betchel$ et# al$ acted$ as$ the$ basis$ for$ the$ first$ set$ of$ experiments$ I$
performed$ in#vitro.$ $Alongside$RASAL1,$which$was$highlighted$ in$this$publication,$ I$
also$decided$to$analyse$other$Ras$GAPs$that$had$been$highlighted$to$play$a$role$in$
liver$ cancer.$ $ As$ in$ the$ publication$ by$ Calvisi$ et# al# they$ demonstrated$ that$ other$
RasGaps$ were$ being$ silenced$ by$ a$ similar$ mechanism$ and$ I$ was$ interested$ to$
understand$if$they$were$having$any$effect$in$renal$fibrosis$(Calvisi,$Ladu$et$al.$2011).$$
There$ is$ currently$ little$ research$ looking$ at$ the$ specificity$ of$ the$ Ras2GAP$





























However,$ in$ model$ 2$ (Appendix$ C$ Error!, Reference, source, not, found.),$ also$ in$
MPTECs,$ TGFβ1$ had$ no$ effect$ on$ RASAL1$ expression$ at$ the$ 24hr$ time$ point,$ but$
gave$ an$ 80%$ reduction$ at$ 120hr$ time$ point.$ $ $ The$ data$ strongly$ suggests$ a$ cell$
dependent$result$in$RASAL1,$however$as$mentioned$previously$proximal$tubule$cells$





vivo,# RASAL1$ expression$ was$ analysed$ in$ CFAN$ mice.$ $ There$ appears$ to$ be$ no$
obvious$pattern$of$expression$of$RASAL1$when$comparing$healthy$and$disease$mice,$
however$ when$ young$ mice$ (Day$ 0)$ of$ the$ model$ and$ older$ mice$ (Day$ 85)$ were$
compared$ they$ appears$ to$ be$ a$ dramatic$ reduction$ in$ RASAL1$ over$ time$ in$ the$





Epigenetic$ regulation$ of$ genes$ in$ kidney$ disease$ is$ a$ growing$ field$ of$ research,$
multiple$studies$have$been$shown$to$be$impacted$by$the$hypermethylation$of$genes.$$
Bechtel$ et# al$ linked$ Ras$ activation$ with$ the$ epigenetic$ changes$ in$ RASAL1$ in$ the$






in$ MPTECs$ was$ due$ to$ changes$ in$ DNA$ methylation,$ methylation$ specific$ PCR$
analysis$was$attempted,$however$this$did$not$work$and$would$requiring$repeating.$$
 
10.2.6 ,Conclusions,
In$conclusion$RASAL1$expression$can$be$inhibited$by$TGFβ1,$however$it$is$unclear$of$
exactly$how$this$is$regulated,$although$it$does$appear$to$be$a$cell$dependent$effect$
seen$in$proximal$tubule$cells.$$$
 
